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CHAPTER 1. INTRODUCTION 
Dissertation Organization 
This dissertation includes a general introduction to plant specialized metabolites 
found in the Hypericum plant genus and their medicinal properties.  The specific focus of this 
dissertation is on acyl-phloroglucinols and drug discovery with studies related to biologically 
active compounds from the medicinal plant Hypericum gentianoides (H. gentianoides).  
Included are chapters adapted from published works, manuscripts in review, and unpublished 
findings.  Chapter 2, modified from a publication in the Journal of Agricultural and Food 
Chemistry, focuses on introducing the chemical diversity found in Hypericum species and 
describes several bioactivities that may be associated with one class of polyketides found in 
several Hypericum species, the acyl-phloroglucinols.  Chapter 3, a manuscript in preparation 
for publication, focuses on the bioactivity guided fractionation of a H. gentianoides extract, 
the subsequent identification of anti-inflammatory compounds from the active fractions using 
various analytical methods, the discussion of their potential as a drug discovery lead, and the 
hypothesis that these compounds may behave synergistically to enhance biological activity.   
Chapter 4, a manuscript in preparation for publication, focuses on the investigation of the 
effect of treating human immunodeficiency virus (HIV) infected HeLa37 cells with H. 
gentianoides extracts and fractions containing acyl-phloroglucinols, and the unusual 
cytotoxicity of these fractions on HeLa cells.  Furthermore, it discusses the affects of these 
acyl-phloroglucinols in another viral infectivity model, equine infectious anemia virus 
(EIAV) in equine dermis cells.  Chapter 5 briefly discusses preliminary investigations of 
Hypericum extracts effects on the physiology of transient receptor vanilloid potential 1 
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(TRPV1) human pain receptors expressed in frog oocytes and human embryonic kidney 
cells.  Chapter 6 briefly discusses the distribution of bioactive acyl-phloroglucinols in 
flowering H. gentianoides plants.  Chapter 7, General Conclusions, ties together the 
hypotheses from these different studies and draws conclusions based on the findings and 
other data from primary literature.  The Appendices include two publications related to this 
dissertation research.  A unified hypothesis for the small-molecule signaling ecological and 
mechanistic role of acyl-phloroglucinols is provided. 
General Introduction 
Natural Product Diversity in Hypericum 
The genus Hypericum L. contains approximately 450 species (Robson, 1977) and is 
currently classified in the family Clusiaceae, also known as Guttiferae Juss. 1789, nom. et 
cons.  However, this genus was previously classified taxonomically under its own family 
named Hypericaceae Juss., nom. et cons.  Hypericum is well known for containing several 
species with pharmacological activity and typically have yellow flowers of varying size and 
petal number; some examples are shown in Figure 1.  The most heavily used and researched 
species is Hypericum perforatum, commonly referred to as St. John’s Wort (SJW).  Used 
since the time of the ancient Greeks, this popular herbal supplement has been studied 
extensively over the past few decades with much progress on understanding the effects of its 
large host of bioactive compounds has on humans and mammalian cell model systems 
(APPENDIX A: Hammer, 2008; APPENDIX B: Hammer, 2007.)   
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H. perforatum 
H. hypericoides 
H. androsaemum 
H. crux-andreae 
H. denticulatum 
H. gentianoides 
 
Figure 1.  Comparison of flower size in six different species of Hypericum. 
 
Many classes of plant metabolites accumulate in Hypericum species including 
monoterpenes, diterpenes, triterpene sterols, phenylpropanoids, aglycone flavonoids, 
glycosylated flavonoids, biflavones, benzophenones, xanthones, acyl-phloroglucinols, 
anthrones, dianthrones, and porphorins (Ernst, 2003).  
In particular, two compounds from H. perforatum that have been extensively studied.  
The first is the dianthrone, hypericin (see Figure 1, p. 25), which was identified as the 
compound responsible for the light-induced photosensitivity caused by the ingestion of SJW 
(Knox, 1985).  Also, hypericin has been linked with the inhibition of human-
immunodeficiency virus by extracts from SJW (Meruelo, 1988).  The second heavily studied 
compound from H. perforatum is hyperforin.  This acyl-phloroglucinol is the suspect 
compound responsible for the anti-depressive activity of SJW (Mennini, 2004).  With that 
said, there is still much that is unknown about how other metabolites in plant extracts are 
modulating or acting synergistically along side hypericin and hyperforin, altering their 
function in the human body.  When the context is expanded from just SJW to the entire 
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genus, it becomes clear how little we know about what small-molecule signaling and other 
chemical ecological interactions specialized metabolites from Hypericum may have.  
The number of specialized secondary small molecules/compounds identified from 
Hypericum species grows each year.  This list is further complicated by the fact that these 
compounds are often enzymatically modified to form a large variety of “hyphenated” class 
compounds.  One example is the addition of terpenoid biosynthesis using polyketides as 
substrates, creating a large class of polyketide-terpenoid compounds.  This is especially 
prevalent in the modification of acyl-phloroglucinols, causing phloroglucinol-terpenoid 
natural product discovery to continue to grow every year.  In Hypericum species alone, there 
are now approximately 60 identified compounds (Inder Pal Singh, 2003).  In all plant species 
surveyed, over 700 acyl-phloroglucinols have been identified (Inder Pal Singh, 2003).  
Although this is only a small subset of terpene class compounds, considering how little 
biochemical and molecular biology research has been completed on the 450 known species 
of Hypericum and related taxa, this number will most likely exponentially increase over the 
next several years. 
The Known Biological Activities of Specialized Compounds from Hypericum 
The Hypericum species is known to contain numerous flavonoids.  Flavonoids are 
present throughout the plant kingdom.  Due to their commonality, we focus on classes of 
compounds more specific to Hypericum and its parent family, Clusiaceae. 
Xanthones 
Xanthones are derived from benzophenones via a cyclization reaction forming a third 
heteronuclear six-member ring.  The Clusiaceae family, including Hypericum contains 
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numerous xanthones.  These compounds are believed to be defense compounds against fungi, 
which is now supported by recent data demonstrating an increase in these compounds after 
H. perforatum cell suspension cultures were treated with Colletotrichum gloeosporioides 
fungal elicitor (Conceição, 2006).  As for bioactivity in other organisms, xanthones are 
known to possess antibacterial properties, anti-inflammatory activity in mammals, and anti-
proliferative properties against cancer cells (Rath, 1996). 
Acyl-phloroglucinols 
 An acyl-phloroglucinol is best defined as a benzene ring with a hydroxylation pattern 
at the 2, 4, and 6 positions and a larger variable acyl-type functional group at position 1.   In 
Hypericum the core acyl-phloroglucinol is biosynthesized by type III polyketide synthases.  
For acyl-phloroglucinols biosynthesis involves the condensation of three malonyl-CoA’s 
with the loss of a carbon each time, and the cyclization of the new six-carbon addition to 
form the 2, 4, 6-hydroxybenzene ring known as “phloroglucinol.”  Type III polyketide 
synthases are believed to have diverged from keto acyl-synthase III (KASIII), which is 
involved in fatty-acid biosynthesis (Austin & Noel, 2002).  The size of the precursor 
substrate can vary considerably from one enzyme to the next.  When the precursor is benzoic 
acid the product is a benzophenone-phloroglucinol, which provides the substrate for the 
biosynthesis of xanthones.  This means that in Hypericum, even xanthones are derived from 
an acyl-phloroglucinol.  Alternatively the substrate may be a branched-chain keto-acid 
derived from branched chain amino acids.  This is the case for the bioactive compound 
hyperforin from St. John’s Wort.  Its precursor is isobutyryl-CoA.   This enzyme has been 
characterized, and was named butyrophenone synthase (BUS) (Klingauf, 2005).  Due to the 
flexibility of these enzymes it is quite possible that the biosynthesis of adhyperforin, also 
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from St. John’s Wort, is derived from the same pathway with BUS utilizing isovaleryl-CoA 
as the substrate as opposed to isobutyryl-CoA.   
Acyl-phloroglucinols are also modified to form complex multi-cyclic ring structures 
and various functional groups such as the polycyclic polyprenylated acyl-phloroglucinols 
(PPAPs) with 100 of such bioactive compounds known (Ciochina 2006).  Furthermore, there 
exist dimers, trimers, and even tetramers of monocyclic acyl-phloroglucinols, chemically 
linked by a methylene, carbonyl, or t-butyl methine group between each unit (Inder Pal 
Singh, 2003).  These complex enzymatic modifications provide a class of compounds with a 
large range of chemical properties.  Hence, this provides the possibility for a multitude of 
effects on other organisms in the plant’s natural habitat or intentional medicinal uses by 
humans.  This becomes more apparent when citing the various reported medically related 
biological activities reported for acyl-phloroglucinols.  In general acyl-phloroglucinols are 
antimicrobial, working against various eukaryotic parasites and bacteria.  Staphylococcus 
species are often inhibited by numerous acyl-phloroglucinols.  A unique notable example is 
the inhibition of Staphylococcus aureus and Mycobacterium smegmatis by dimeric acyl-
phloroglucinols from Hypericum drummondii (Jayasuriya, 1991).  Other known biological 
activities include anti-inflammatory properties (Ishii, 2003), cytotoxicity, anti-proliferation of 
cancer cells, binding to the pregnane X receptor causing up-regulation of cytochrome p450 in 
humans (Moore, 2000), antiviral properties against numerous viruses (Nakane, 1991), anti-
depressive activity in humans (Mennini, 2004), and acting as antioxidant properties 
(Coichina, 2006; Inder Pal Singh, 2003).  In this dissertation the focus is on the anti-
inflammatory activity of acyl-phloroglucinols and how it relates to other bioactivities. 
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Inflammation as a disease and its relationship with other diseases 
It is now recognized that there is a link between inflammatory responses in mammals 
and the development of chronic diseases relating to altered metabolism and signaling in cells.  
Altered lipid metabolism from genetic disorders can cause the development of 
neurodegenerative diseases such as multiple sclerosis (MS), Parkinson’s disease, 
schizophrenia, epilepsy, and Huntington's disease (HD); which have intricate associations 
with inflammatory pathways (Adibhatla, 2008).    Brain injury can induce inflammatory 
responses that lead to atherosclerosis.  Furthermore, inflammation can lead to strokes due to 
the breakdown of plaques in individuals with atherosclerosis causing blockages in the brain 
(Adibhatla, 2008).  All of these conditions are intimately linked to inflammatory responses. 
Another important observation in medical research was that the inducible 
cyclooxygenase-2 (COX-2) enzyme, involved in inflammatory responses, is highly expressed 
in cancerous tissues (Balkwill, 2001).  This led to the testing of numerous anti-inflammatory 
compounds for the inhibition of numerous types of cancer cells.  For example, the selective 
cyclooxygenase-2 inhibitor, Celebrex, has been proven to inhibit and modulate certain types 
of cancers in humans (Balkwill, 2001).  Infiltration of macrophages in malignant tissue may 
be responsible for the COX-2 induction observed.  Chemokines regulate this infiltration, 
acting as chemical trails leading the macrophages to the site of inflammation.  Additionally, 
certain cytokines maintain the health of these macrophages.  In particular, the cytokine tumor 
necrosis factor (TNF) has been shown to be a key regulator of cell death and regeneration in 
damaged tissues.  Furthermore, TNF has been implicated in up regulation of the cytokine 
monocyte chemotactic protein-1, which regulates macrophage infiltration and 
metalloproteinase-9.  Also, modulation of cannabinoid receptors and transient receptor 
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potential vanilloid-1 (TRPV1) receptor may affect the infiltration of macrophages via the up 
regulation of metalloproteinases.  Although normally associated with pain response, more 
recently these receptors have been shown to play important roles in preventing the infiltration 
of tissues by cancer cells via the increased expression of metalloproteinase-1 (Ramer, 2008). 
When the relationships between genetic diseases and the links between the different 
bioactivities that one class of small-metabolites can have on humans are correlated a much 
larger question emerges; are all of these processes mediated by a single regulatory system?  
What sort of homeostatic control could modulate all cell processes?  This dissertation focuses 
on metabolite diversity studies in Hypericum medicinal species and identifying the small-
molecules responsible for anti-inflammatory activity, modulating pain receptors, and anti-
viral activity. 
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CHAPTER 2.  CHARACTERIZING THE METABOLIC 
FINGERPRINT AND ANTI-INFLAMMATORY ACTIVITY OF 
HYPERICUM GENTIANOIDES 
 
Modified from a paper published in the Journal of Agricultural and Food Chemistry 
 
Matthew L. Hillwig *, †, ‡, Kimberly D.P. Hammer †, #, Diane F. Birt †, #, Eve Syrkin 
Wurtele*, †, ‡ 
 
 
Abstract 
 
In this paper we characterize the metabolic fingerprint and first reported anti-
inflammatory activity of Hypericum gentianoides.  H. gentianoides has a history of 
medical use by Native Americans, but it has been studied very little for biological 
activity.  High-performance liquid chromatography (HPLC) and liquid chromatography-
electrospray ionization-mass spectrometry (LC-ESI-MS) analyses of a methanol extract 
show that H. gentianoides contains a family of over nine related compounds that have 
retention times, mass spectra, and a distinctive UV absorption spectra characteristic of 
certain acyl-phloroglucinols.  These metabolites are abundant relative to other secondary 
products present in H. gentianoides accounting for approximately 0.2 grams per gram of 
dry plant tissue.  H. gentianoides methanol extracts and a specific semi-preparative 
HPLC fraction from these extracts containing the putative acyl-phloroglucinols, reduce 
prostaglandin E2 synthesis in mammalian macrophages. 
Introduction 
 
The Hypericum genus contains over 450 species; the 75 to 80 species that have 
been surveyed for phytochemicals to date are rich in secondary metabolites such as type 
* To whom correspondence should be addressed:  Tel: (515) 294-3509.  E-mail: 
mhillwig@iastate.edu or mash@iastate.edu 
† Center for Research on Botanical Dietary Supplements 
‡ Department of Genetics, Development, and Cell Biology at Iowa State University 
# Department of Food Science and Human Nutrition at Iowa State University 
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III polyketides including flavonoids, xanthones, anthrones, dianthrones, and/or acyl-
phloroglucinols (Ernst, 2003).  Type III polyketides result from the condensation of 3 
malonyl-CoA molecules and various precursor substrates including or derived from  
branch chain amino acids, shikimate-derived phenylpropanoids, benzoic acid, and acetyl-
CoA (Fatland, 2005) (Figure 1).  Divergent type III polyketide synthases (PKS) have 
evolved to create this wide variety of clade-specific polyketides.  Chalcone synthase was 
the first type III PKS to be characterized, and is the best known (Kreuzaller, 1972).  The 
flavonoids observed in Hypericum species, such as hyperoside, rutin, isoquercitrin, 
quercitrin and quercetin, are derived from this enzyme’s product, naringenin chalcone.  
The type III PKS responsible for emodinanthrone biosynthesis is unknown; however, 
biosynthesis of the dianthrone hypericin from emodinanthrone (Figure 1) has been 
characterized (Bais, 2003).  In light of this diversity, the Hypericum genus represents a 
great reserve for the discovery of new bioactive compounds and advancing our 
understanding of the underlying mechanisms that cause the reported bioactivities in 
humans. 
Several Hypericum species, in particular H. perforatum, are used as herbal 
treatments for anti-inflammatory, antibacterial, antiviral, and anti-depressive applications 
(Mennini, 2004; Rocha, 1996; Rabanal, 2005).  The numerous classes of compounds 
found in this single species may explain these multiple medicinal uses.  For example, 
acyl-phloroglucinols have multiple bioactivities, including antibacterial activity in TLC 
bioautographic assays (Rocha, 1996) and antidepressive properties in humans (Mennini, 
2004).  Hypericum species are particularly rich in acyl-phloroglucinols (Singh, 2006).  
Acyl-phloroglucinols are derived from the condensation of multiple malonyl-CoA 
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molecules and branch chain amino acid derivatives (Klingauf, 2005).  These acyl-
phloroglucinols are also often prenylated, as is the case with hyperforin (Boubakir, 2005).  
Acyl-phloroglucinols already identified from Hypericum species include hyperforin and 
adhyperforin, perforatumone, uliginosin A and B, bromouliginosin B, drummondins A-F, 
saroaspidins A-C, hyperbrasilols A-C, and numerous sarothralens and japonicines, 
paglucinol, annulatophenone, hypericophenonoside, hyperjovinol A, otogirin, 
italidipyrone, chinesins I and II, and sampsonines (Rocha, 1996; Singh, 2006). 
Anti-inflammatory activity in mammals and mammalian cells has been reported 
for more than one species from the Hypericum genus (El-Seedi, 2003; Rabanal, 2005; 
Sanchez-Mateo, 2006; Tedeschi, 2003); however, it is unknown whether this is caused by 
the same compound(s) in each of these species.  This anti-inflammatory activity has been 
confirmed by both in vivo studies treating mice with Hypericum extracts and measuring 
pain reduction using the formalin test (Sanchez-Mateo, 2006) and in vitro molecular 
studies on H. patulum showing the down-regulation of NF-κB and the effect of this on 
PGE2 reduction in LPS-induced C6 rat glioma cells (Yamakuni, 2006).  Extracts or 
compounds from H. reflexum reduce inflammatory responses (Sanchez-Mateo, 2006), H. 
laricifolium moderately reduce cyclooxygenase 1 and 2 activity (El-Seedi, 2003), and H. 
perforatum reduce inducible nitrous oxide synthase activity in two human epithelial cell 
lines (Tedeschi, 2003), indicating a direct effect of certain Hypericum metabolite extracts 
on reducing inflammation. 
A few North American species of Hypericum have been used historically for their 
medical properties.  One such species, H. gentianoides (orangegrass), is a small perennial 
that is native to much of the eastern United States.  The Cherokee Native Americans used 
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this plant for the treatment of fever, gastrointestinal disorders, nosebleeds, sores, and 
venereal disease (Hamel, 1975).  Despite its use by Native Americans, there has been 
very little biochemical research on this species.  A survey study looking for the presence 
of nine known compounds of interest in 74 Hypericum species found that H. gentianoides 
did not contain hypericin or hyperforin (Crockett, 2005), the two metabolites thought to 
be the major bioactive constituents of H. perforatum (Schmitt, 2006; Hammer, 2007).  
Because our initial survey of multiple Hypericum species indicated unusual metabolites 
are present in H. gentianoides, and because of the use of this species by Native 
Americans, we focus on the potential bioactivity of this species. 
Here, we describe an efficient, non-destructive extraction method for Hypericum 
metabolites and a semi-preparative separation method for fractionation of the H. 
gentianoides extracts.  Using these protocols, we describe the unique metabolite profile 
of H. gentianoides and demonstrate the anti-inflammatory activity of this species. 
Materials and Methods 
 
Extracts 
 
Plant material was collected in October 2004 and September 2005 from two 
populations of H. gentianoides growing in their native habitats in South Carolina by Dr. 
Joe-Ann McCoy of the USDA-ARS North Central Regional Plant Introduction Station in 
Ames, IA.  These populations were accessioned in the US National Plant Germplasm 
System as Ames 27657 and Ames 28015.  Descriptive information about these accessions 
is posted in the Germplasm Resources Information Network (GRIN) database at 
http://www.ars-grin.gov/npgs/.  Voucher specimens of these accessions have been 
deposited at the Iowa State University Ada Hayden Herbarium.  The aboveground 
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portion of mature flowering plants was harvested and allowed to dry naturally in a 
herbarium press before use. 
To maximize the discovery of potentially bioactive metabolites, we developed 
extraction methods for Hypericum to optimize both the preservation of unstable 
compounds and the extraction efficiency of a broad range of compounds.  Methods such 
as soxhlet extraction are efficient; however, such methods can destroy thermally unstable 
compounds (Liu, 2000).  We ground plant material in liquid nitrogen and used sonication 
to avoid altering the compounds during extraction to minimize the degradation of easily 
oxidized compounds potentially in H. gentianoides, such as prenylated acyl-
phloroglucinols.       
Dry plants were ground in liquid nitrogen and 30 grams of ground tissue 
immersed in 100 mL of methanol.  The methanol/tissue was sonicated, with the tube in 
ice, using a Cole-Parmer (Chicago, Ill. 60648) 4710 Series Ultrasonic Homogenizer for 
30 s three times.  Samples were then centrifuged at 15,000 rcf and the supernatant 
decanted and filtered through 0.45 micron nylon syringe filters.  Solvent was evaporated 
under nitrogen gas at 40° C to prevent oxidation.  Four grams of dry plant material 
yielded approximately one gram of extracted methanol-soluble metabolites.  The dried 
extract was dissolved in cell culture grade dimethyl sulfoxide (DMSO) (Sigma, St. Louis, 
MO).   
Extraction using an ethanol-water mixture was avoided, despite efficient 
extraction, because high temperatures and/or long periods of time in a lyophilizer or 
evaporator are required to remove the water when the sample is concentrated.  Methanol 
was a more logical choice since that solvent could be evaporated easily and quickly. 
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Furthermore, it effectively extracted a broad range of compounds similar to those 
extracted using 70% ethanol as the solvent (Supporting Information). 
High-Performance Liquid Chromatography (HPLC)  
 
A Beckman Coulter (Fullerton, CA) HPLC with a Detector 160 photo diode array 
(PDA) detector was used for initial chemical profiling.  A Synergi Max-RP 4 micron 150 
x 4.6 mm column (Phenomenex, Torrance, CA 90501) was used for analytical separation.  
For the mobile phase, an acetonitrile/methanol 9:1 v/v (solvent B) and 10 mM 
ammonium acetate (solvent A) gradient was used.  The gradient consisted of 87% A/13% 
B in 10 min to 83% A/17% B, then to 100% B in 25 min and held for 5 min, at 40° C.  
The flow rate was 1.0 mL/min (Ganzera, 2002).  All solvents were HPLC grade (Sigma, 
St. Louis, MO).  All standards mentioned where purchased from Chromadex, Irvine, CA. 
Liquid Chromatography-Electrospray Ionization-Mass Spectrometry (LC-ESI-MS) 
 
 The extracts were also analyzed with an Agilent Technologies Ion Trap 1100 LC-
ESI-MS.  A Synergi Max-RP 4 micron 150 x 4.6 mm column (Phenomenex, Torrance, 
CA 90501) was used for analytical separation.  For the mobile phase an 
acetonitrile/methanol 9:1 v/v (solvent B) and 10 mM ammonium acetate (solvent A) 
gradient was used.  The gradient was increased from 85%A/15%B over a 10 min time 
period to 80% A/20% B, then to 100% B over a 25 min time period, and held at 100% B 
for 5 min, at 40° C.  The flow rate was 0.75 mL/min (Ganzera, 2002).  This method and 
the HPLC method where chosen for their good separation and short run-time compared to 
other current methods used for the analysis of Hypericum extracts.  All solvents were 
HPLC grade (Sigma, St. Louis, MO). 
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Semi-preparative HPLC 
 
 Semi-preparative scale HPLC was used for bioactivity-guided fractionation since 
it is very reproducible and requires only gram quantities of starting material.  A Synergi 
Max-RP 4 micron 250x10 mm column (Phenomenex Torrance, CA 90501) was chosen, 
because its stationary phase matches that of the analytical method.  For the mobile phase, 
an acetonitrile/methanol 9:1 v/v (solvent B) and 10 mM ammonium acetate (solvent A) 
gradient elution was used; 13-15% B in 10 min, 15-100% B in 30 min, 100% B for 5 
min, at 40° C.  The slow rise from 13% to 15% over 10 min optimized the separation of 
more polar phenylpropanoids from later eluting flavonoids.  While a range of flow rates 
from 3-5 mL/min were tested, a flow rate of 4.6 mL/min was selected because it 
optimized separation of compounds while matching retention times with the analytical 
method within 3 min or less.  All solvents were HPLC grade (Sigma, St. Louis, MO). 
Cell Cultures and Treatments 
 
RAW264.7 macrophages were cultured as described in Hammer, 2008.  For 
details see Supporting Information.  Cells were incubated in media containing 0.1% 
DMSO (Sigma, St. Louis, MO), or media with the inclusion of a H. gentianoides extract 
or fraction dissolved in DMSO for a final DMSO concentration of 0.1% of the media to 
match the controls, with or without 1 µg/ml LPS (E. coli 02B:B6) (Sigma, St. Louis, 
MO).  Cell supernatants were collected on ice, and stored in a -70° C freezer until used in 
the PGE2 assay (Supporting Information).  Four controls were included for each 
experiment: media alone, media and DMSO, media and LPS, and media and LPS and 
DMSO.  For the PGE2 assays, treatment of cells with 10 µM quercetin was used as a 
positive control.  The H. gentianoides methanol extract, and fractions 1 and 2, were dried 
 17
under nitrogen gas, weighed, and dissolved in DMSO.  The concentration tested in µg/ml 
(dry weight) represents the final concentration of the extract, or fraction, in the media.  
For cytotoxicity studies (Supporting Information), treatment of cells with 20 µM 
hypericin was used as a positive control (Schmitt, 2006). 
Statistical Analysis of Bioactivity and Cytotoxicity Data  
Anti-inflammatory activity was calculated as mean percent of control in LPS-
induced PGE2 levels (± standard error) as compared to the media + LPS + DMSO control.  
Statistical significance was determined by an F-protected two-way ANOVA followed by 
a Tukey-Kramer test for multiple comparisons (Snedecor, 1989).  For cytotoxicity, data 
were calculated as mean % cell viability (± standard error) as compared to the media + 
DMSO control.   Statistical significance was determined by an F-protected two-way 
ANOVA followed by a Dunnett-Hsu test for multiple comparisons (Dunnett, 1955).  P-
values less than 0.05 were considered statistically significant. 
RESULTS 
 
Metabolic Profile of H. gentianoides 
 
HPLC-PDA analysis of H. gentianoides extracts, using the methanol-low 
temperature extraction method revealed a complex chromatographic profile (Figure 2A).  
A wavelength of 270 nm is used for detection in Hypericum extracts surveyed because a 
wide range of polyphenolic compounds absorb well at that wavelength.  Chlorogenic acid 
(A), hyperoside (B), isoquercitrin (C), quercitrin (D), and quercetin (E), are present in H. 
gentianoides as determined by HPLC-PDA with standards (Figure 2A).  The presence of 
A, B, and C are in accordance with (16), who used a different H. gentianoides accession. 
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Other than the presence of chlorogenic acid and the four flavonoids listed, H. 
gentianoides has a very distinct chemical profile compared to that of H. perforatum.  
Unlike many of the bioactive species in the Hypericum genus (Crockett, 2005), neither 
hypericin (a dianthrone) nor hyperforin (an acyl-phloroglucinol), the two most heavily 
studied bioactive compounds from St. John’s Wort (Hammer, 2007; Schmitt, 2006), are 
present in H. gentianoides.  In addition, the ultraviolet (UV) radiation absorption spectra 
of the HPLC UV-absorbing metabolites reveal a class of related compounds with a 
retention time from 30-45 min; there are at least nine metabolites (Figure 2B) with 
distinctive UV absorption maxima at 220, 300, and 350 nm; or at 226, 287, and 357 nm; 
and the correlating LC-ESI-MS data (Supporting Information). 
Also, LC-ESI-MS was used to provide additional physical information about 
compounds in the methanol extract used for fractionation and the anti-inflammatory 
assays.  The total ion chromatograph (TIC) shows that about 79% of the mass in the 
methanol extract consists of compounds with a retention time between 30 and 35 min, 
and these compounds comprise 2% of the fresh weight of the plant (Figure 3).  This value 
was calculated using the combined peak area from 30-35 min on the total ion 
chromatogram (TIC) compared to the total combined peak area from 0-45 min, and the 
extract yield from the original extraction.  These nine TIC peaks correlate with the nine 
UV-absorbing metabolites, as shown with the corresponding mass to charge ratios and 
retention times shown in Figure 2B. 
Anti-inflammatory Activity of H. gentianoides 
 
To evaluate the biological activity of H. gentianoides extracts in mammals, we 
used a RAW264.7 mouse macrophage model system, in which LPS is used to induce an 
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inflammatory response (Hammer, 2007).  The ability of H. gentianoides extracts to 
reduce the inflammatory response was evaluated by quantifying PGE2 production in LPS-
induced macrophages and comparing to the solvent control (Hammer, 2007).  Bioassays 
using extracts prepared from accessions Ames 28015 and Ames 27767 of H. gentianoides 
both produced a significant reduction of PGE2, compared to the controls.  To establish the 
concentration of extract needed to demonstrate anti-inflammatory activity, macrophages 
were treated with various concentrations of plant extract from 10-50 μg/mL.  This 
revealed a dose response, with decreasing PGE2 accumulation the higher the 
concentrations of the extract applied (Figure 4). 
Since H. perforatum contains light-activated compounds, the H. gentianoides 
extract was tested in dark conditions and after light treatment (Schmitt, 2007) to 
determine whether the reduction in PGE2 was dependent on light activation.  There was 
no significant difference in inhibition of PGE2 between the light-activated and dark 
treatment conditions (data not shown).  Therefore, subsequent experiments were 
performed in light-activated conditions alone.  This confirms results shown in Hammer et 
al. (Hammer, 2007) in which H. perforatum extracts also had light-independent anti-
inflammatory activity.  Also, cytotoxicity was not dependent on light-activation because 
there was no significant difference between light-activated and dark treatment conditions 
(Supporting Information).  The data validates our hypothesis that H. gentianoides extract, 
unlike extracts of H. perforatum (Blank, 2001; Blank, 2004), does not contain any 
compounds such as hypericin that would cause an increased cytotoxicity following light-
activation. 
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Semi-Preparative HPLC 
 
To determine which classes of compound(s) are responsible for the bioactivity, 
and specifically to evaluate the bioactivity of the unidentified metabolites with the 
distinct UV absorption spectra, a semi-preparative HPLC method was developed to 
fractionate the H. gentianoides extract.  This optimized protocol achieves good 
separation, has a high loading capacity, the same compound elution order as the 
analytical separation data, and allows for the isolation of enough fraction material for 
biological testing in a reasonable amount of time.  As an initial test to determine whether 
the bioactivity in the H. gentianoides extract might be associated with the less polar 
metabolites with the unique UV spectra, we collected a fraction from 0-30 min (fraction 
1) and a fraction from 30-45 min (fraction 2).  Analytical HPLC separation compares the 
composition of the extract, to that of the more polar fraction containing numerous 
phenylpropanoids and flavonoids (fraction 1) and the less polar fraction (fraction 2) 
(Figure 3).  This effectively separated the compounds with the distinct 230/300/350 UV 
absorption maxima fingerprint (fraction 2), from the flavonoids and phenylpropanoids, to 
access if they are responsible for the observed anti-inflammatory activity.  The UV data 
for Figure 3 is shown at 350 nm because of the distinct absorption maxima at 350 nm for 
the compounds of interest in fraction 2. 
Anti-inflammatory Activity of H. gentianoides Fractions 
 
LPS-induced RAW 264.7 macrophages were treated with one of the two HPLC 
fractions or with the original extract.  Fraction 2 significantly reduced the PGE2 
concentration in the LPS-induced cells at doses of 30 µg/mL and 10 µg/mL, while 
fraction 1 did not reduce the PGE2 concentration at the same doses.  This indicates that 
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the active constituents are in fraction 2 (Figure 5).  However, fraction 2 has a small 
amount of significant reduction in cell viability at these concentrations.  Further testing 
revealed that fraction 2 significantly reduces PGE2 concentrations at doses even as low as 
1 μg/mL (Figure 5).  At 5 and 1 μg/ml, there was no significant reduction in cell viability, 
suggesting that these compounds have anti-inflammatory activity even at these lower 
doses in which cytotoxicity is not a concern. 
Discussion 
 
In recent years metabolomics has accelerated as a field of study (Nikolau & 
Wurtele, 2007; Feihn, 2002; Hall, 2002).  Not only can we use such tools to understand 
the biochemistry of an organism and its evolutionary relationship to its environment, but 
also to identify the compounds responsible for inter-organism biological activities.  
Recent research on the effect of botanicals on epigenetic events (Shay, 2005) and cell 
signaling in mammals (Gerisch, 2007) implicates that numerous small molecules most 
likely play a large part in the health and life cycle of cells.  These findings suggest there 
are many more unique small molecules that have yet to be discovered, which may play 
crucial roles in cell signaling.  Developing better extraction, separation, and detection 
methods is crucial for the identification of bioactive constituents not yet discovered. 
 We developed an extraction method for H. gentianoides designed to minimize 
degradation of unstable compounds, and a fractionation method for bioactivity-guided 
separation of the extract.  Using these procedures, we determined that extracts from H. 
gentianoides reduce concentrations of the pro-inflammatory compound PGE2 in LPS-
induced RAW 264.7 macrophages, and demonstrated that fraction 2 significantly reduces 
PGE2 at doses as low as tested, 1 µg/mL, with no significant reduction in cell viability at 
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this dose.  This bioactivity is present in extracts from both accessions of H. gentianoides 
sampled, indicating that the bioactivity is characteristic of at least two populations of this 
species. 
The reduction in PGE2 concentration by the H. gentianoides extract may reflect 
reduced cyclooxygenase activity, since prostaglandin H is the product of this class of 
enzyme, and believed to be the substrate for the biosynthesis of PGE2 by prostaglandin E 
synthase.  The mechanism by which this PGE2 reduction is modulated is under 
investigation. 
The characteristic UV absorption fingerprints, retention times, and molecular ions 
of at least nine HPLC peaks from the bioactive fraction 2, which are described in Figure 
2 and in Supporting Information, indicate that its most abundant constituents may be 
structurally and/or biosynthetically related, and are consistent with those of certain types 
of acyl-phloroglucinols (Rocha, 2006).  Our working hypothesis is thus that the anti-
inflammatory compounds of H. gentianoides are acyl-phloroglucinols. These compounds 
may not have been tested previously for anti-inflammatory properties considering how 
few molecular cell biology and biochemical studies on North American Hypericum 
species have been published.  This complicates the identification of bioactive constituents 
given that they must be identified with NMR since there are no standards available.  
Fraction 2 contains many compounds besides the nine aforementioned peaks of interest 
and identification of the bioactive metabolites is in progress, using iterative sub-
fractionation, bioactivity assays, ion trap and quadrapole-time-of-flight (QTOF) LC-MS, 
and 2D-NMR spectroscopy.      
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Furthermore, the distinct morphology as well as the potent anti-inflammatory 
bioactivity, and unusual chemical profile of H. gentianoides, relative to other Hypericum 
species from Eurasia and North America, justify further investigation.  A study 
comparing the chemical profiles of species in the Section Brathys, to which H. 
gentianoides belongs, and species in Section Trigynobrathys, since these sections have a 
similar unusual morphology, would enrich the understanding of evolutionary cohorts of 
H. gentianoides. 
Abbreviations Used 
 
HPLC=High performance liquid chromatography 
PDA=Photo diode array 
LC-ESI-MS=Liquid chromatography-electrospray ionization-mass spectrometry 
PGE2=Prostaglandin E2  
LPS=Lipopolysaccharide 
Safety 
 
Acetonitrile, methanol, ammonium acetate, and dimethylsulfoxide are toxic 
chemicals that should be used in a fume hood. 
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Figure 1.  Hypericum species have evolved a wide array of specialized Type III 
polyketide synthases (PKS) that produce polyketides that may interact with various 
receptors/mechanisms/components of potential pathogens, symbionts, predators and 
pollinators.  Type III polyketides result from the condensation of 3 malonyl-CoA molecules and various 
precursor substrates including branch chain amino acids, shikimate-derived phenylpropanoids, benzoic 
acid, and acetyl-CoA.  Sometimes these polyketides are modified by other enzymes, for example by 
prenylation, as with gamma-mangostin (a xanthone) and hyperforin (an acyl-phloroglucinol).  The boxes 
represent Type III PKS’s responsible for specific reactions that form the precursors for secondary 
metabolites in Hypericum: chalcone synthase (CHS), benzophenone synthase (BPS), and isobutyrophenone 
synthase (BUS); and the Type III PKS responsible for emodinanthrone biosynthesis (not isolated).  The 
biosynthesis of the dianthrone hypericin from emodinanthrone has been characterized. 
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Figure 2.  H. gentianoides contains a distinct set of metabolites not found in H. 
perforatum.  A.) HPLC chromatography of methanol extracts from H. gentianoides and H. perforatum.  
Metabolites detected in H. gentianoides and not in H. perforatum are indicated with numbers.  Also, many 
of the abundant secondary metabolites in H. gentianoides are not found in H. perforatum.  LC-MS analysis 
(mass spectra not shown) indicates hypericin and hyperforin, ubiquitous in H. perforatum, are not detected 
in H. gentianoides.  B.) The UV absorption fingerprints of the unknown numbered lipophilic compounds in 
H. gentianoides are similar, indicating the associated compounds may be related biosynthetically.  The 
mass to charge ratio of the molecular ions from complementary LC-MS data are listed next to their 
associated UV absorption fingerprint as well.  See Supporting Information for the mass spectra of peaks 1-
9.  
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Figure 3.  Semi-preparative HPLC separation of H. gentianoides methanol extract.  
A methanol extract was subjected to semi-preparative HPLC and two fractions collected, dividing the more 
lipophilic constituents (fraction 2) from the more polar constituents, rich in flavonoids such as quercetin 
(fraction 1), as shown in this analytical LC-UV-MS data.  The total ion chromatograph (TIC) from the 
liquid chromatography-electrospray ionization-mass spectrum analysis shows that the unknown lipophilic 
compounds (highlighted in the box) based on TIC peak area, comprises approximately 79% of the 
methanol extract’s mass, accounting for 2% of the plant fresh weight.  This high abundance will facilitate 
purification of enough material for bioactivity-guided fractionation starting with only tens of grams of dry 
plant material. 
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Figure 4.  H. gentianoides methanol extract significantly reduces PGE2 
concentrations in LPS-induced RAW 264.7 macrophages.  Cells were treated with 1 µg/ml 
LPS and the H. gentianoides extract simultaneously for 8 hours.  Decreased PGE2 indicates increased anti-
inflammatory activity.  Anti-inflammatory activity is given as mean percent of control (culture media + 
DMSO + LPS PGE2 level ± standard error) and cytotoxicity is given as mean percent of cell viability of 
control (culture media + DMSO ± standard error) compared to that of H. gentianoides extracts (n=6 for 
each).  The concentration of the extract tested, in µg/ml dry weight, represents the final concentration of the 
extract in the media.  Addition of LPS to the culture media + DMSO control increased the level of PGE2 
11-fold over culture media + DMSO control alone (0.12± 0.02 ng/ml for media + DMSO, 1.4 ± 0.1 ng/ml 
for media + DMSO + LPS).  Extracts in the culture media without LPS did not affect the concentration of 
PGE2 as compared to the media + DMSO control.   * p-value less than 0.05 as compared to the control.   
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Figure 5.  H. gentianoides fraction 2 significantly reduces PGE2 concentrations 
in LPS-induced RAW 264.7 macrophages.  Decreased PGE2 indicates increased anti-
inflammatory activity.  Anti-inflammatory activity is given as mean percent of (media + DMSO + 
LPS PGE2 level ± standard error) and cytotoxicity is given as mean percent of (media + DMSO cell 
viability ± standard error), for fractions 1 and 2, and for extracts of H. gentianoides (n=4 for each).  
The concentration of the extract tested, in µg/ml dry weight, represents the final concentration of the 
extract in the media.  Fraction 2 significantly reduced PGE2 concentrations at all doses tested and 
shows no cytotoxicity at doses of 5 μg/mL or less.   * p-value less than 0.05 as compared to the 
control.  ** p-value less than 0.0001 as compared to the control. 
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Supporting Information 
 
Supporting Information 1 
Cell Culture 
 
RAW264.7 macrophages were purchased from the American Type Culture 
Collections (ATCC; Manassas, VA) and cultured as described in Hammer, 2008.  Cells 
were maintained in 75 cm2 flasks in a 5% CO2 incubator with 70% humidity for 37° C, in 
high glucose Dulbecco’s Modified Eagle’s medium (4500 mg/L D-glucose) (Invitrogen; 
Carlsbad, CA) and supplemented with 100 UI/ml penicillin/streptomycin (Invitrogen; 
Carlsbad, CA) and 10% Fetal Bovine Serum (FBS) (Invitrogen; Carlsbad, CA), until 
approximately 70% confluent (18).  The limulus (LAL) test was performed to ensure 
lipo-polysaccharide (LPS) was not present in the cell cultures prior to treatments 
(Hammer, 2008). 
PGE2 Assay 
The cell culture supernatant samples were assayed using a prostaglandin E2 
(PGE2) EIA kit (GE Biosciences, Piscataway, NJ) according to manufacturer’s 
instructions.  Supernatants were diluted to ensure the concentrations of PGE2 present 
were within the linear range of the standard curve. 
Cytotoxicity Assay 
CellTiter96® Aqueous One Solution cell proliferation assay (Promega 
Corporation, Madison, WI) was used as previously described (Schmitt, 2007) except that 
an 8 hour treatment incubation was used for comparing directly to the PGE2 data.  The 
number of viable cells for each treatment was compared to the media + DMSO solvent 
control.  Treatment of cells with 20 µM hypericin was used as a positive control. 
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Supporting Information 2 
 
Overlaid HPLC-UV absorption data shows that the H. gentianoides methanol metabolite 
extract has a very similar composition to that of a 70% ethanol H. gentianoides 
extraction. 
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Supporting Information 3 
There is no difference in cell viability between treatment of LPS-induced RAW 264.7 
macrophages with the H. gentianoides extract in the light or dark compared to the 
control. 
 
 
 
Cytotoxicity is given as mean percent of cell viability of control (culture media + DMSO 
± standard error).  *p-value less than 0.05 as compared to control (n=4). 
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Supporting Information 4 
LC-MS total ion chromatograph and molecular ion mass spectra (negative ion mode) 
data, for the H. gentianoides methanol extract, corresponding to numbered peaks in the 
HPLC data in Figure 2A and 2B. 
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Abstract 
 
Hypericum gentianoides extracts reduce prostaglandin E2 (PGE2) levels in cultured 
macrophages (Hillwig, 2008); the biochemical constituents of this rarely-used medical plant 
have not been identified.  To identify the bioactive components associated with the anti-
inflammatory activity, we used bioactivity-guided separation of H. gentianoides extracts as 
measured by reduced PGE2 concentrations in LPS-induced RAW264.7 macrophages, 
combined with analytical analysis of the constituents of bioactive fractions by electrospray 
ionization-mass spectrometry (ESI-MS) and nuclear magnetic resonance (NMR).  Three 
compounds were identified that individually possess anti-inflammatory activity.  These are 
saroaspidin A (C24H30O8), uliginosin A (C28H36O8), and hyperbrasilol C (C32H42O8).  
Saroaspidin A, the most potent of the three, reduces PGE2 levels at concentrations as low as 2 
µM. 
Introduction 
 
Chronic inflammation is a major health problem today.  Chronic inflammation can 
induce pain (Watkins, 2001; Fiset, 2003) and a range of studies detail an association between 
* To whom correspondence should be addressed:  Tel: (515) 294-3509.  E-mail: 
mhillwig@iastate.edu or mash@iastate.edu 
† Center for Research on Botanical Dietary Supplements 
‡ Department of Genetics, Development, and Cell Biology at Iowa State University 
# Department of Food Science and Human Nutrition at Iowa State University 
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chronic inflammation and cancer (Balkwill, 2001).  More recent evidence implicates a 
relationship between inflammation and central nervous system disorders such as multiple 
sclerosis and Parkinson’s disease (Adibhatla, 2008).  In general, cyclooxygenase-2 (COX-2) 
activity is markedly increased in diseased tissues (Adibhatla, 2008).  This observation has 
driven research aimed at finding ways to reduce the activity of the inducible COX-2 in 
diseased tissues.  One approach is to investigate the complex biochemical interactions plant 
natural products have on inflammatory responses.   
Recently, Hypericum gentianoides, a plant species used medicinally by the Cherokee 
people (Hamel, 1975), was shown to reduce the concentration of prostaglandin E2 (PGE2) in 
lipo-polysacharride (LPS)-induced RAW264.7 macrophages (Hillwig, 2008).  To identify the 
specific bioactive components associated with this anti-inflammatory activity, we used 
bioactivity-guided separation of H. gentianoides extracts.  Here, we report the chemical 
structures of the bioactive active components. 
Materials and Methods 
 
Plant material and extraction 
 
Shoots of flowering H. gentianoides, accessions Ames 27657 and Ames 28015 
(Germplasm Resources Information Network, GRIN; http://www.ars-grin.gov/npgs/); 
voucher specimens located at Iowa State University Ada Hayden Herbarium, 
(www.public.iastate.edu/~herbarium/) were collected in their native habitat in October, 2004 
and September, 2005, and were extracted in methanol using a liquid nitrogen-sonication 
method to minimize degradation (5). 
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Fractionation 
 
Fractions were prepared using semi-preparative HPLC as previously described 
(Hillwig, 2008) using a Synergi Max-RP 4 micron 250x10 mm column (Phenomenex 
Torrance, CA 90501).  Four-hundred mg of H. gentianoides extract was injected into the 
HPLC (50 mg/500 µL injection, 8 injections).  Fractions were collected at minute intervals 
from 30 min to 45 min, dried under nitrogen gas, weighed, and dissolved in culture grade 
DMSO (Sigma, St. Louis, MO).  Fractions that were determined to be bioactive were re-
chromatographed by HPLC for further purification of constituents using either the same 
method or a modified mobile phase gradient method.  The modified mobile phase gradients 
were developed specifically for acyl-phloroglucinols using the same stationary phase.  The 
same column as mentioned above was used for the stationary phase.  For the mobile phase, 
an acetonitrile/methanol 9:1 v/v (solvent B) and 10 mM ammonium acetate (solvent A) 
gradient elution was used; 50-100% B in 15 min, 100-50% B in 1 min, 50% B for 3 min for 
the re-equilibration period, at 40° C. 
Electrospray Ionization-Mass Spectrometry (ESI-MS) 
Semi-preparative HPLC fractions were diluted in methanol to a concentration of 0.1-
1.0 mg/mL, depending on the fraction, and infused into an Agilent Ion Trap 1100 mass 
spectrometer for 1.5 min at 5 µL/min.  The ion trap was used to acquire tandem MS/MS 
spectra, and subsequently for directed fragmentation of specific molecular ions to MS5.  To 
determine the masses of molecular ions, samples were dissolved in methanol were infused 
into an ABI LC/MS-Q Star tandem mass spectra-time of flight spectrometer for 5 min at 5 
µL/min. 
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Macrophage Anti-inflammatory Model  
PGE2 concentration was assayed in a lipopolysaccharide (LPS)-induced RAW264.7 
macrophage assay (Hillwig, 2008).  The limulus test (Hammer, 2007) was performed to 
ensure LPS was not present in the cell cultures prior to treatments.  Four controls were 
included for each experiment: media alone, media and DMSO, media and LPS, and media 
and LPS and DMSO. 
Protein blot 
Protein from RAW264.7 cells used in the anti-inflammatory assays.was probed for 
COX-1 and COX-2 as previously described (APPENDIX A: Hammer, 2008). 
NMR 
Samples were dissolved in 300 µL deuterated methanol (CD3OD), placed in Shigemi 
tubes, and held at 313 K in a 700 MHz Bruker liquid-phase NMR instrument.  The small 
amount of each compound (2-10 mg) made the acquisition of a complete 1-D carbon-13 
spectra unfeasible, thus multiple 2-D NMR experiments were used for structural 
determinations; chemical shifts listed in Tables 1-3 represent composites of datasets from 
two heteronuclear coupling methods (HMBC, HSQC) and qqfCOSY. 
Results 
 
To identify the specific molecule(s) associated with the bioactivity, HPLC fractions 
were collected at minute intervals from 30 min to 45 min, and assayed for their ability to 
reduce PGE2 levels in LPS-induced RAW263.7 macrophages (Figure 1).  Fractions (and 
constituent biochemicals) were bioassayed according to their relative natural abundance in 
the plant extract, hence, the absolute amounts of material tested varied according to the 
fraction.  ESI-MS data for these one-minute fractions is shown in Figure 2.  Initial 
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hypotheses as to the chemical structure of bioactive compounds relied heavily on multiple 
tandem mass spectrometry (MSn) to provide repeated guided fragmentation of daughter ions. 
Four of the 15 fractions reduced PGE2 levels significantly:  32-33 min reduced PGE2 
concentrations by 87% at a dose of 5.6 µg/mL, 34-35 min by 85% at dose of 19.2 µg/mL, 35-
36 min by 93.5% at a dose of 7.2 µg/mL, 38-39 min by 88% at a dose of 3.2 µg/mL (Figure 
1).  Since fractions containing mainly molecular ions 359 m/z, 431 m/z, 569 m/z, 497 m/z, 
567 m/z, 621 m/z did not reduce PGE2 levels, compounds having molecular ions of 445 m/z, 
499 m/z, or 553 m/z were associated with the anti-inflammatory activity (Figure 2). 
Semi-preparative HPLC was used to further separate the components of fraction 32-
33 min, fraction 35-36 min, and fraction 38-39 min.  ESI-MS data for these sub-minute 
fractions is shown in Figure 3.  PGE2 assays of these sub-minute fractions showed fraction 
32-32.6 min to have the greatest bioactivity, followed by fraction 33.8-34.2 min (Figure 4).  
Although no sub-fraction of 38-39 min showed significant bioactivity, sub-fraction 38.0-38.3 
reduced PEG2 activity and contains a small amount of the compound with 499 m/z, as well as 
several other constituents.  Fraction 32-32.6 min was of particular interest because of the 
ability of this fraction to reduce PGE2 concentrations at the lowest dose applied, 1 µg/mL, 
while the subsequent fraction, 32.6-33.4 min, was inactive.  Liquid chromatography-mass 
spectrometry (LC-MS) analysis, using an Agilent Ion Trap 1100, showed that fraction 32-
32.6 min contained two main compounds at 497 m/z and 445 m/z, with molecular ion 445 
m/z being the more abundant (Figure 3).  Tandem MS/MS of the 445 m/z ion parent ion 
showed a tight cluster of daughter ions with approximately half the m/z ratio, indicating a 
possible dimeric chemical structure (Supporting Information). 
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LPS induces accumulation of COX-2 polypeptide, but not COX-1 polypeptide, in the 
macrophages (10). Fraction 32-32.6 min was tested for its ability to reduce COX-1 and COX-
2 polypeptides in LPS-induced macrophages.  Western blot results indicate that fraction 32-
32.6 min reduces accumulation of cyclooxygenase-2, but not cyclooxygenase-1, at a dose of 
10 µg/mL (Figure 5).  Fraction 38-39 min also reduces accumulation of cyclooxygenase-2, 
but not cyclooxygenase-1, at a dose of 10 µg/mL (Figure 5). 
Identification of Anti-inflammatory Compounds 
 
Further purification of fraction 32-32.6 min by semi-preparative HPLC led to the 
isolation of 2 mg of pure compound (445 m/z) from 30 g of the original dry plant material (8 
g of the original plant extract).  Using two-dimensional (2-D) nuclear magnetic resonance 
(NMR) spectroscopy experiments including heteronuclear multiple bond correlation 
(HMBC), quadruple-quantum filtered correlation spectroscopy (qqfCOSY), and 
heteronuclear single quantum correlation (HSQC), the chemical structure of the compound 
(445 m/z) was elucidated (Figure 3).  The chemical structure was cross-referenced to a 
previously identified compound, saroaspidin A (Ishiguro, 1987).  The compound contains a 
phloroglucinol moiety and a filicinic acid moiety.  
Two more compounds from bioactive fractions were purified and their chemical 
structures solved using the 2-D NMR methods described above.  Compounds 499 m/z and 
553 m/z have been identified as uliginosin A (MW 500) and hyperbrasilol C (MW 554) 
(Rocha, 1996).   Both of these are structurally similar to saroaspidin A containing 
phloroglucinol moieties and filicinic acid moieties.  Conversely, both of them, unlike 
saroaspidin A, are prenylated at 10’ while hyperbrasilol C is additionally prenylated at 
position 4 (Figure 5).  The HMBC correlations are shown in Figure 5, with spectral data in 
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Tables 1-3.  Interestingly, other fractions containing mainly one or the other compound did 
not have as great of bioactivity as the two together, namely fraction 35-36 min from Figure 3.  
These data indicate there may be a synergistic effect between uliginosin A and hyperbrasilol 
C, which would explain the increased bioactivity when both are applied as a treatment 
together.  The active constituents in fraction 38-39 and its subminute fractions are still under 
investigation. 
MS-TOF Spectrometry 
 
MS-TOF data supports the NMR based structures for the bioactive compounds.  The 
exact mass of the molecular ions in negative mode were: 445.1974 m/z, 499.2587 m/z, 
553.3017 m/z.  These values support the chemical formulas of saroaspidin A (C24H30O8), 
uliginosin A (C28H36O8), and hyperbrasilol C (C32H42O8) when the mass of a proton is added 
back to the molecular ion exact mass; yielding the molecular exact mass.   
Reduction of PGE2 levels by Purified Saroaspidin A, Uliginosin A, and Hyperbrasilol C 
 
As little as 2 µM of purified saroaspidin A applied to the LPS-induced macrophages 
significantly reduced PGE2 concentrations (Figure 7).  Doses of 10 µM or lower were not 
detectably cytotoxic.  Doses of 100 µM reduced viability by about 20%.  Purified uliginosin 
A and hyperbrasilol C were also screened for PGE2 reducing activity using the same anti-
inflammatory assay (Figures 8 and 9).  These compounds significantly reduce PGE2 levels 
down to a concentration of 10 µM.  Furthermore, uliginosin A shows no significant 
cytotoxicity until 100 µM, and hyperbrasilol C shows no detectable cytotoxicity even at 100 
µM.   
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Discussion 
 
In conclusion, we used a combination of HPLC, ESI-MS, 2-D NMR techniques, and 
bioactivity guided fractionation to identify three dimeric acyl-phloroglucinols from a 
methanol extract of H. gentianoides plant material; saroaspidin A, uliginosin A, and 
hyperbrasilol C, each of which possesses anti-inflammatory activity as measured by reduced 
PGE2 concentrations in LPS-induced RAW264.7 macrophages. To our knowledge, none of 
these have ever previously been tested for anti-inflammatory activity, and saroaspidin A and 
uliginosin A have never been tested on eukaryotic cells for any bioactivity.  Saroaspidin A 
has been shown to be antibacterial in a screening assay (Ishiguro, 1987).  Dimeric 
compounds specifically from related Hypericum species have antibacterial activity against 
gram positive and Mycobacteria (Jayasuriya, 1991), antimalarial properties (Cheng, 1988) 
and cytotoxicity against various cancer cells lines (Jayasuriya, 1991; Sing, 2006).  Notably, 
all three of the compounds reported here in H. gentianoides have been previously tested and 
found to have antibacterial properties (Ishiguro, 1987; Rocha, 1996).  The previous findings 
of anti-cancer properties are of most interest when considering the aforementioned link 
between cancer and inflammation.  Here we have shown that multiple dimeric acyl-
phloroglucinols reduce PGE2, which suggests a link between this anti-inflammatory activity 
and anti-tumor affects observed from related compounds. 
 Saroaspidin A reduces the concentration of the inducible COX-2 in macrophages 
during an inflammatory response.  In contrast, the constitutively expressed cyclooxygenase-1 
(COX-1) does not appear to be affected.  This suggests that saroaspidin A is selectively 
inhibiting COX-2, a major target for treating chronic inflammatory diseases (Watkins, 2001).  
Furthermore, the dimeric acyl-phloroglucinols have been identified in H. gentianoides and 
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are shown to have anti-inflammatory activity, and there appear to be synergistic effects when 
certain combinations of these are applied for treating inflammatory responses; specifically, 
the fact that results show certain fractions containing more than one of the identified 
compounds have increased bioactivity.  There are conserved structures amongst all three 
isolated bioactive compounds (Figure 10).  However, saroaspidin A more potently reduces 
PGE2.  Furthermore, the western blot demonstrates that treatment with the other identified 
acyl-phloroglucinols (uliginosinA and hyperbrasilol C) did not specifically inhibit COX-2 
versus COX-1 at the doses tested; suggesting R1 being an isobutyryl group and R4 being a 
methyl group is important for this specificity.  This specificity is further supported by the fact 
that not all of the suspect phloroglucinols from H. gentianoides possess anti-inflammatory 
activity.  
 The mass spectra from the semi-preparative HPLC fractions and the UV absorption 
fingerprints from our previous work (Hillwig, 2008) show the presence of numerous other 
putative acyl-phloroglucinols with far less potency than the three identified examples 
discussed here.  H. gentianoides is a “rich” source of secondary metabolites, defined as 
accumulating numerous biosynthetically related compounds, exemplifying the diversity of 
nature’s library of small-molecules.  This supports the “screening” or “diversity based” 
model of secondary/specialized metabolism (Firn, 2003; Fischbach, 2003).  In addition, our 
working hypothesis is that these compounds are interacting pieces in a synergistic schema 
necessary for the full complement of activity against their target peptides.  The bioactivity 
reported here suggests that these compounds may be of interest for further studies identifying 
the specific molecular mechanisms involved, and providing a starting point for drug 
discovery research.  Further evaluation of the synergistic affects among these compounds and 
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fractions, which may explain further anti-inflammatory activity, is ongoing.  In addition we 
continue to investigate less abundant putative acyl-phloroglucinols from H. gentianoides that 
may help explain what structural differences are important for the more potent anti-
inflammatory compounds and how the biosynthetic pathways synthesizing these compounds 
behave. 
Abbreviations Used 
 
HPLC=High performance liquid chromatography 
LC-ESI-MS=Liquid chromatography-electrospray ionization-mass spectrometry 
PGE2=Prostaglandin E2  
LPS=Lipopolysaccharide 
NMR=Nuclear magnetic resonance 
HMBC=Heteronuclear multiple bond correlation 
qqfCOSY=Quadruple-quantum filtered correlation spectroscopy  
 HSQC =Heteronuclear single quantum correlation  
COX-1=Cyclooxygenase-1 
COX-2=Cyclooxygenase-2 
Safety 
 
Acetonitrile, methanol, ammonium acetate, and dimethylsulfoxide are toxic chemicals that 
should be used in a fume hood. 
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Table 1.  Spectral Data for compound MW 446 (445.1974 m/z M-). 
 
C 
chemical shift 
(ppm) H' 
chemical shift 
(ppm) 
1 184    
2 105    
3 195 3-OH 16.44 
4 52 4-Me 1.26 
4-Me 24 5-OH 16.44 
5 201    
6 n.o.    
7 17.3 7 3.48 
8 211    
9 38.4 9 4.18 
9-Me 18.5 9-Me 1.16 
1' 107.5    
2' 161.5 2'-OH n.o. 
3' 103    
3'-Me 21 3'-Me 1.97 
4' 161.5 4'-OH n.o. 
5' n.o.    
6' 157 6'-OH n.o. 
7' 199.7    
8' 33.8 8' 3.92 
8'-Me 18.3 8'-Me 1.13 
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Table 2. Chemical shift data for compound MW 500 (499.2587 m/z M-).  
 
C 
Chemical shift 
(ppm) H' 
Chemical shift 
(ppm) 
1 194.5    
2 105.4    
3 184.5 3-OH n.o. 
4 49.9    
4-Me 56.5 4-Me 1.23 
5 197.5 5-OH 19.32 
6 111.9    
7 18 7 3.5 
8 210.7    
9 38.5 9 4.15 
9-Me 18.6  1.17 
2' 129.7    
2'-Me 16.5 2'-Me 1.65 
" 24.6 " 1.76 
3' 123.1 3' 5.1 
4' 21.3 4' 3.26 
5' 160.8 5-OH n.o. 
6' 107.6    
7' 157.7 7'-OH 13.84 
8' 106.9     
9' 160.8 9'-OH n.o. 
10' 107.6    
11' 199.9    
12' 33.5 12' 3.55 
12'-Me 18.6 12'-Me 1.14 
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Table 3.  Spectral Data for compound MW 554 (553.3017 m/z M-). 
 
 
C 
Chemical shift 
(ppm) H' 
Chemical shift 
(ppm) 
1 193.2    
2 107    
3 184.5 3-OH n.o. 
4 48.8    
5 193.2 5-OH 19.33 
6 115.7    
6-Me 19.2 6-Me 1.93 
7 16.7 7 3.47 
2' 129.7    
2'-Me 16.5 2'-Me 1.57 
" 24.5  1.7 
3' 123.2 3' 5.11 
4' 21.4 4' 3.2 
5' 160.8 5-OH 9.62 
6' 107.7    
7' 157.4 7'-OH 9.62 
8' n.o.    
9' n.o. 9'-OH 9.62 
10' 107.7    
11' 199.9    
12' 33.5 12' 3.92 
12'-Me 18.6 
12'-
Me 1.1 
1" n.o. 1" 3.19 
     3.4 
2" 123.2 2" 5.11 
3" 129.7    
3"-Me 16.5 3"-Me 1.57 
" 24.5 " 1.7 
1"' 210.8    
2"' 39.1 2"' 4.19 
2"'-Me 18.6 2"'-Me 1.08 
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Figure 1.  Four one-minute H. gentianoides fractions reduce PGE2 levels.  Decreased 
PGE2 indicates increased anti-inflammatory activity.  Anti-inflammatory activity is given 
as mean percent of (media + DMSO + LPS PGE2 level ± standard error) and cytotoxicity 
is given as mean percent of (media + DMSO cell viability  ± standard error) for H. 
gentianoides fractions (n=4 for each).  * p-value less than 0.05 as compared to control.   
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Figure 2.  ESI-MS showing molecular ions (M-1) for the one-minute semi-preparative 
HPLC fractions. 
 
 
 
 
 52
 
 
44 5.1
4 59 .1
49 7.0
51 4.9
-M S ,  11 .0 -13 .0 m in (#6 00 -# 80 2)
0
2
4
6
6x1 0
40 0 45 0 50 0 55 0 60 0 65 0 70 0 75 0 80 0 85 0 m / z
4 31 .1
44 5.0
49 7.0
51 5.0 5 69 .0
-M S ,  10 .9 -13 .0 m in (#7 27 -# 92 4)
0
2
4
6x1 0
40 0 45 0 50 0 55 0 60 0 65 0 70 0 75 0 80 0 85 0 m / z
459 .1
499.1
513 .1
553 .1
5 69 .0
-MS, 11 .2 -13 .0m in (#619 -#800)
0.0
0.5
1.0
7x10
400 450 500 550 600 650 700 750 800 850 m/z
499.1
551.0 5 69 .1
-MS, 11 .2 -13 .0m in (#619 -#798)
0.0
0.5
1.0
1.5
7x10
400 450 500 550 600 650 700 750 800 850 m/z
49 9.1
55 1.1
56 7.2
5 81 .3 62 1.3
6 47 .3
72 1.0
7 35 .2
-M S ,  11 .2 -13 .0 m in (#6 13 -# 78 7)
0. 0
0. 5
1. 0
1. 5
6x1 0
40 0 45 0 50 0 55 0 60 0 65 0 70 0 75 0 80 0 85 0 m / z
32-32.6
32.6-33.4
33.8-34.2
34.2-34.7
38-38.35
62 1.4
661.3 735 .2
-MS, 11 .2 -13 .0m in (#616 -#786)
0.00
0.25
0.50
0.75
7x10
400 450 500 550 600 650 700 750 800 850 m/z
49 7.1
62 1.4
6 47 .2 7 01 .3
7 35 .3
78 9. 2
-M S ,  11 .2 -13 .0 m in (#6 21 -# 79 1)
0
2
4
6x1 0
40 0 45 0 50 0 55 0 60 0 65 0 70 0 75 0 80 0 85 0 m / z
38.4-38.6
38.6-38.9
 
 
Figure 3.  ESI-MS molecular ion data showing molecular ions (M-1) for sub-minute 
semi-preparative HPLC fractions. 
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Figure 4.  Two subminute fractions significantly reduce PGE2 in LPS-induced 
RAW264.7 macrophages at the lowest dose tested, 1 µg/mL.  Alternatively, the subminute 
fractions containing the compounds found in the the original 38-39 fraction had reduced 
activity compared to 38-39.  Decreased PGE2 indicates increased anti-inflammatory activity. 
Anti-inflammatory activity is given as mean percent of (media + DMSO + LPS PGE2 level ± 
standard error) and cytotoxicity is given as mean percent of (media + DMSO cell viability  ± 
standard error) for H. gentianoides fractions (n=4 for each).  * p-value less than 0.05 as 
compared to control. 
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Figure 5.  Quantified western blot.  Cyclooxygenase-2 is significantly reduced in LPS-
induced RAW263.7 macrophages treated with the 32-32.6 min fraction and 38-39 min 
fraction compared to the control.  This suggests a specific interaction affecting the 
inducible cyclooxygenase-2 after the LPS induced inflammation response while the 
constitutively expressed cyclooxygenase-1 is unaffected.  Treatments were replicated 3 times 
(1 blot/treatment) and normalized by blot to positive control for consistency.  For the control 
there was no difference in COX-2 protein level without LPS (media + DMSO vs. treatments) 
and no difference in COX-1 protein level without LPS (media + DMSO vs. treatments). * p-
value less than 0.05 as compared to positive control (media + DMSO).  The control (ctrl) on 
the blot is a blotting control. 
 
 
 
 
 
 
 
 
 
 
 55
A
O
O
OHHO 4
8'
2' 5
6
3'
9
2
4 ' 3
86'
OH
HO
O
OH
5'
7
11'
7'
 
B
1
4
8'
2'
7
5' 5
6
3'
10'
2
4'
3
7'
9'
6'
12'
11'
OH
OH
O
HO OH
O
HO
O
8
9
 
1
4
8'
2'
7
5' 5
6
3'
10'
2
4'
3
7'
9'
6'
12'
11'
OH
OH
O
HO OH
O
HO
O
1'' 2''
3''
1'''2'''
 
C 
 
Figure 6. A.) Two-dimensional NMR spectroscopy HMBC correlations confirming the 
structure of the bioactive compound MW 446 with the molecular ion 445 m/z (M-) as 
saroaspidin A, as compared to Ishiguro et al., 1987. B.) Two-dimensional NMR spectroscopy 
observed HMBC correlations supporting the structure of bioactive compound MW 500 with 
the molecular ion 499 m/z (M-) is that of uliginosin A, as compared to Rocha et al., 1995. 
Overlapping signals are not shown.  C.)  Two-dimensional NMR spectroscopy observed 
HMBC correlations confirming bioactive compound MW 554 with the molecular ion 445 
m/z (M-) is that of hyperbrasilol C, as compared to Rocha et al., 1996. 
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Figure 7.  LPS-induced RAW264.7 macrophages treated with saroaspidin A (MW 446) 
isolated from H. gentianoides have reduced prostaglandin E2 concentrations at doses as 
low as 2 µM (2 µM is equivalent to 0.89 µg/ml).  Anti-inflammatory activity is given as 
mean percent of (media + DMSO + LPS PGE2 level ± standard error) and cytotoxicity is 
given as mean percent of (media + DMSO cell viability  ± standard error) for H. gentianoides 
fractions (n=4 for each).  * p-value less than 0.05 as compared to control.  
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Figure 8.  LPS-induced RAW264.7 macrophages treated with uliginosin A (MW 500), 
isolated from H. gentianoides, have a significant reduction of prostaglandin E2 
concentrations at or above a tested dose of 10 µM in the cell media (10 µM is equivalent 
to 5.01 µg/ml).  Anti-inflammatory activity is given as mean percent of (media + DMSO + 
LPS PGE2 level ± standard error) and cytotoxicity is given as mean percent of (media + 
DMSO cell viability  ± standard error) for H. gentianoides fractions.  * p-value less than 0.05 
as compared to control. 
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Figure 9.  LPS-induced RAW264.7 macrophages treated with hyperbrasilol C (MW 
554), isolated from H. gentianoides, have a significant reduction of prostaglandin E2 
concentrations at or above a tested dose of 10 µM in the cell media (10 µM is equivalent 
to 5.55 µg/ml).  Anti-inflammatory activity is given as mean percent of (media + DMSO + 
LPS PGE2 level ± standard error) and cytotoxicity is given as mean percent of (media + 
DMSO cell viability  ± standard error) for H. gentianoides fractions.  * p-value less than 0.05 
as compared to control. 
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Figure 10.  Conserved structural regions amongst saroaspidin A, uliginosin A, and 
hyperbrasilol C.  The left ring system is defined as an acyl-phloroglucinol and portion 
highlighted in red is conserved between all three compounds.  The right ring system is 
defined as a 3, 5-hydroxy-cyclohexadienone (filicinic acid) moiety with a ketoacyl group 
located at R1 or R2 or R3; and the portion highlighted in blue is also conserved amongst all 
three compounds.  These two rings are bonded together by a methylene bridge, which is 
common to all structures.  In saroaspidin A and uliginosin A, R1 is an isobutyryl group. 
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Abstract 
 
Numerous plant species contain phytochemicals that inhibit the human 
immunodeficiency virus (HIV).  St. John’s wort is one botanical that has been shown to 
contain HIV inhibiting compounds.  We investigated an extract from a related medicinal 
plant, Hypericum gentianoides, for antiviral properties. An extract and fractions from H. 
gentianoides inhibit HIV.  However, the compounds contained therein are also cytotoxic to 
the HeLa cell line used for the assay.  Furthermore, we investigated the effect of the extract 
and fractions on the infectivity of the equine infectious anemia virus (EIAV), a related 
lentivirus, in equine dermis cells.  We hypothesize that identified acyl-phloroglucinols do 
inhibit lentiviruses but are cytotoxic to certain mammalian cell types at high concentrations.  
These acyl-phloroglucinols may also be good leads for anti-cancer studies. 
Introduction 
Numerous natural products have been found to inhibit human immunodeficiency 
virus (HIV) often with different proposed targets including virus adsorption, virus-cell 
fusion, reverse transcription, integration, transcription, and translation (De Clercq, 2000).  
For instance, one important compound with potent HIV inhibition is betulinic acid (Fujioka, 
1994) and specifically 3-O-(3’,3’-dimethylsuccinyl)betulinic acid (Kanamoto, 2006).  
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However, the mode of action is not yet fully understood.  Another important example is the 
calanolides, a group of coumarin derivatives that inhibit HIV (Kashman, 1992).  
Furthermore, numerous phloroglucinols derivatives have previously been reported to inhibit 
HIV.  These include laxifloranone (Bokesch, 1999), macrocarpal M-B (Nishizawa, 1992), 
vismiaphenone D (Fuller, 1999), and mallotochromene or mallotojaponin (Nakane 1991).  
Another source of HIV inhibition is St. John’s Wort (Hypericum perforatum).  It is well 
established that compounds from St. John’s Wort demonstrate inhibitory affects, on certain 
envelop viruses, particularly human immunodeficiency virus (HIV) (Richman, 1991).  
Conversely, this botanical supplement also has adverse effects, such as photo dermatitis from 
the hypericin and up-regulation of cytochromes, which aggravates the degradation of drugs 
in vivo (Gödtel-Armbrust, 2007).  However, there are other species in the Hypericum genus 
used medicinally which may provide an alternative that does not possess these side-effects.  
Furthermore, the compound(s) responsible for the St. John’s Wort anti-HIV activity are not 
fully understood.  Studying other species of Hypericum may provide further insight in to the 
bioactivity observed in St. John’s Wort and provide a source for new drug discovery.  The 
Hypericum genus of plants contains species rich in bioactive secondary metabolites such as 
flavonoids, xanthones, dianthrones, and acyl-phloroglucinols (Ernst, 2003).  Phloroglucinols 
are of a particular interest since they have multiple known bioactivities themselves, including 
anti-viral activity, anti-bacterial activity, and anti-depressive properties in humans (Inder Pal 
Singh, 2006). 
Hypericum gentianoides (orangegrass) is a small perennial that is native to much of 
the eastern United States.  Although it was previously used medicinally by Native 
Americans, there is very little research published on this species.  The rational for studying 
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this particular species was our initial studies identifying unique metabolites in H. 
gentianoides (Hillwig, 2008) and its medicinal use by the Native Americans (Hamel, 1975).  
One of these uses was for treatment of venereal diseases, although it is not understood what 
that specifically referred to (viral or bacterial).  In light of this we used envelope virus model 
systems to test what, if any, unique affects on human immunodeficiency virus (HIV) 
infectivity metabolites from this species of Hypericum, might have using in vitro HIV and 
EIAV inhibition assays.    Here in this paper we report HIV and EIAV inhibition by acyl-
phloroglucinols from a methanol extract of H. gentianoides and the bioactivity guided 
fractionation of this extract, to elucidate the bioactive constituents responsible. 
Materials and Methods 
Plant Material 
These H. gentianoides populations are accessioned in the US National Plant 
Germplasm System as Ames 27657 and Ames 28015.  Information about these accessions is 
posted in the Germplasm Resources Information Network (GRIN) database at 
http://www.ars-grin.gov/npgs/.  Voucher specimens of these accessions have been deposited 
in the herbarium at Iowa State University.  The aboveground portion of mature flowering 
plants was harvested and allowed to dry naturally in a herbarium press before use. 
Extraction Protocol 
Dry plants were extracted as described in Hillwig, 2008.  The dried extract was 
weighed and dissolved in cell culture grade DMSO (Sigma, St. Louis, MO). 
Semi-preparative HPLC 
 A Synergi Max-RP 4 micron 250x10 mm column (Phenomenex Torrance, CA 
90501) was used on a Beckman Coulter HPLC with a Detector 160 PDA detector 
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(CHAPTER 3: Hillwig, in review).  For the mobile phase, an acetonitrile/methanol 9:1 v/v 
(solvent B) and 10 mM ammonium acetate (solvent A) gradient elution was used; 13-15% B 
in 10 min, 15-100% B in 30 min, 100% B for 5 min, at 40° C.  All solvents used were HPLC 
grade (Sigma, St. Louis, MO).  The extract was injected repeatedly for fractions to yield 
enough material for assays (Hillwig, 2008).  All fractions collected were dried under nitrogen 
gas and re-solubilized in cell culture grade DMSO for cell assays (Sigma, St. Louis, MO). 
Electrospray Ionization-mass spectrometry (ESI-MS) 
For mass spectrometry analysis of the methanol extract and semi-preparative HPLC 
fractions were infused in to an Agilent Technologies Ion Trap 1100 ESI-MS was used 
(CHAPTER 3: Hillwig, in review). 
NMR 
 A 700 MHz Bruker liquid-phase NMR instrument was used for sample analysis.  All 
samples were dissolved in 300 uL of deuterated methanol (CD3OD) and placed in Shigemi 
tubes.  All samples were held at 313 K (Hillwig, in review). 
HIV Infections and Cell Viability Assays 
 Viral stocks of the infectious molecular clone, pNL4-3, were used for all studies 
(Adachi, 1986).  To generate stocks, 15 cm plates of 293T were transfected with pNL4-3 
using a calcium phosphate precipitation.  Supernatant was collected at 24, 48 and 72 h, post 
transfection.  Viral titers were determined as previously described (Reed-Inderbitzin, 2003) 
using HeLa 37 cells that express CD4 and both chemokine co-receptors CCR5 and CXCR4 
(Platt, 1998).   
 Single hit assays were performed as previously described (Reed-Inderbitzin, 2003).  
Hela37 cells were distributed in a 48 well plate (20,000 cells/well) 24 hours prior infection.  
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The media (DMEM supplemented with 10% FCS and Penicillin/ Streptomycin) was removed 
and replaced with fresh media containing HIV with and without serial dilutions of the H. 
gentianoides extract described above.  Between 0.0025 and 0.005 multiplicity of infection 
(MOI) of virus was added to each well. DMSO concentrations were adjusted so that all wells 
contained equivalent concentrations and DMSO concentrations were never greater than 1%.  
All treatments were performed in triplicate.  Virus and cells were incubated at 37° C. for 40 
h.  At the completion of the assay, cells were fixed 10 min with 75% acetone/25% water 
solution and then immunostained utilizing human anti-HIV antisera (kind gift of Dr. J. 
Stapleton, Univ. Iowa), followed by HRP-conjugated goat anti-human IgG.  AEC was 
utilized as the HRP substrate.  HIV antigen-positive cells were counted and recorded.  Wells 
treated with extracts were compared to the control, infected wells.  Data are presented as the 
number of HIV positive cells in the presence of extract/ the number of HIV positive cells in 
the absence of extract. 
Cell viability studies were performed using ATPLite (Packard Instruments) as 
previously described (Maury, 2003).  The ATPLite kit measures the level of ATP present in 
the cell population and is a reliable estimate of cell numbers present.  HeLa 37 cells were 
treated in triplicate with serial dilutions of extracts or equivalent concentrations of the 
vehicle, DMSO.  Cultures were maintained for 40 h and harvested for analysis in parallel 
with the HIV infection plates.  Plates were rinsed once with PBS and lysed per 
manufacturer’s instructions.  Substrate was added and the plates were read in a microtiter 
plate reader at 430 nm.  Data are presented as the ATP activity present in the well in the 
presence of extract/the ATP activity present in the well in the absence of extract. 
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EIAV Infectivity Assays 
Studies were performed in equine dermis cells (ED cells) (ATCC CCL57).   2.5 x 102 
infectious particles of EIAV were combined with the concentrations of extracts or fractions 
noted in the figure.  All whole plant extracts or fractions were resuspended in DMSO.  The 
amount of DMSO was adjusted so that equivalent concentrations of DMSO were used in all 
wells.  No more than 1.5% DMSO was used as ED cell cytotoxicity was observed at higher 
DMSO concentrations.   The extract and virus mixture was added to 5 x 104 cells/well of ED 
cells in a 48 well format.   Cells were maintained for 40 h then fixed with 75% acetone/25% 
water fixation and anti-EIAV immunostaining of the cells as previously described (Maury, 
1994).  The EIAV antigen-positive cells within the infected cell monolayer were counted and 
titers were determined.  In all experiments, cells were infected with an MOI of 0.005.    
Results 
HIV Infectivity Assays 
 Initial single hit HIV infectivity assays and cytotoxicity testing described above were 
performed on Hela37 cells treated with the methanol extract from H. gentianoides.  These 
initial results indicated the H. gentianoides extract reduces HIV infectivity compared to 
controls and that the relative amount of cytotoxicity was low per concentration (Figure 1).   
These initial findings warranted further investigation to elucidate the constituents in the 
extract responsible for the reduced HIV infectivity. 
 Thereafter, Hela37 cells treated with fractions prepared from the original methanol 
extract using semi-preparative HPLC (Hillwig, 2008), were subjected to single hit HIV 
infectivity assays and cytotoxicity testing once more.  The findings indicate that the anti-HIV 
activity is found in specific fractions (Figure 2).  In particular, cells treated with fraction 35-
 68
36 min had a HIV infectivity reduction of 80%.   Also, fraction 34-35 reduced HIV infection 
by approximately 60%.  These fractions’ compositions are shown in Figure 3.  Treatment of 
the infected HeLa37 cells with the H. gentianoides extract and subsequent fractions turned 
out to cause strong cytotoxicity (Figure 2).  This was a unique side effect since previous 
studies using the same H. gentianoides extract with different mammalian cells lines did not 
respond with nearly as much cytotoxicity as the Hela37 cell line (Hillwig, 2008). 
EIAV Infectivity Assays 
Treatment of EIAV infected equine dermis cells with the same H. gentianoides 
fractions tested in the HIV assay revealed that the same specific fraction, 35-36 min, was the 
inhibitoriest to EIAV infection as with HIV (Figure 4).  The concentration tested in Figure 4 
was cytotoxic to the treated cells as well.  However, later testing at lower concentrations 
inhibited EIAV infectivity but was not cytotoxic to the cells (Figure 5).  Dilutions of the 
stock solution for fractions 34-35 and 35-36 were applied to cells and there is a dose response 
with increased concentrations of fraction 35-36 min having increased anti-viral activity 
(Figure 6).  Treatments with 35-36 min with a dose between 4 µg/mL and 10 µg/mL had the 
best anti-viral activity while maintaining low cytotoxicity. 
Elucidation of Bioactive Constituents 
ESI-MS analysis with the Agilent 1100 Ion Trap from MS to MS5 revealed a 
consistent fragmentation pattern of the compounds found in the bioactive H. gentianoides 
suggesting dimeric chemical structures (CHAPTER 3: Hillwig, in review).  The chemical 
structure of bioactive constituents was elucidated using two-dimensional NMR analysis, with 
HMBC, HSQC, and dqfCOSY experiments.  The two major compounds present in fractions 
34-35 min and 35-36 min were purified and identified in our previous work (CHAPTER 3: 
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Hillwig, in review).  These two compounds are dimeric acyl-phloroglucinols; uliginosin A 
and hyperbrasilol C.  In addition, there is one other minor constituent in fraction 35-36 min 
that is still being investigated. 
Discussion 
The ethnobotanical information for H. gentianoides points to treatment of venereal 
disease.  Although this is vague there is modern scientific research supporting this use 
regardless of the interpretation.   There are examples of dimeric acyl-phloroglucinols such as 
hyperbrasilol B reducing the viral titer of herpes simplex virus-1 (Fritz, 2007).  In addition, 
there are studies supporting that dimeric phloroglucinols from Hypericum species are also 
anti-bacterial (Rocha, 1996).  So in either case, bacterial or viral, this is an area that warrants 
further investigation.   
Our studies with two lentivirus infectivity model systems, HIV and EIAV, indicate 
there is inhibition of viral infectivity by extracts and fractions from H. gentianoides 
containing the identified acyl-phloroglucinols; uliginosin A and hyperbrasilol C.  Although, 
both were tested as near pure compounds in fractions 34-35 and 36-37 min uliginosin A was 
not as effective and hyperbrasilol C not at all, compared to when combined together in 
fraction 35-36 min.  However, the underlying mechanism behind this synergistic effect is 
unknown.  Furthermore, the same acyl-phloroglucinols from H. gentianoides disrupt viral 
infection in more than one lentivirus suggesting a common mechanism for this inhibition.  
The H. gentianoides extracts and fractions were cytotoxic to the HeLa37 cancer cell line and 
equine dermis cells at higher concentrations.  Our previous studies with these same extracts 
and fractions had far less of an affect on treated RAW263.7 macrophages (Hillwig, 2008).  
We propose that HeLa37 cells are highly sensitive to apoptosis when treated with acyl-
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phloroglucinols from H. gentianoides.  We are investigating other constituents from the H. 
gentianoides whole extract which may be responsible for additional anti-viral activity 
observed initially.  These results also indicate that acyl-phloroglucinols from H. gentianoides 
may be good candidates for further studies on treating EIAV infection in vivo. 
Abbreviations Used 
LC-MS=Liquid chromatography-mass spectrometry 
HIV=Human immunodeficiency virus 
EIAV=equine infectious anemia virus 
Safety 
Acetonitrile, methanol, ammonium acetate, and dimethylsulfoxide are toxic chemicals that 
should be used in a fume hood. 
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Figure 1. H.  gentianoides methanol extract reduces HIV infection in vitro, while 
cytotoxicity at the same concentration was comparatively low (n=3). 
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Figure 2.  H. gentianoides fraction 35-36 min reduces HIV infection by 77% while 
fraction 34-35 min reduces infection by 62% compared to the control (n=3). 
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Figure 3.  ESI-MS data for the two HIV inhibiting H. gentianoides fractions. 
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Figure 4.  H. gentianoides fraction 35-36 min reduces EIAV infectivity by 50% with 
similar cytotoxicity (n=3). 
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Figure 5.  H. gentianoides fraction 35-36 min reduces EIAV infectivity by 75% at the 
dose tested (for 35-36 min 1 µL/mL = 7.2 µg/mL) (n=3). 
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Figure 6.  Dose response of EIAV infected equine dermis cells treated with H. 
gentianoides fraction 34-35 min and 35-36 min.  The cell viability begins to decrease 
between the 1:9 and 1:3 dilutions. (1:9 = 4.0 µg/mL, 1:3 = 12 µg/mL for 35-36; 1:9 = 10.7 
µg/mL, 1:3 = 32 µg/mL for 34-35) (I=infectivity; V=viability of cells) (n=3). 
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CHAPTER 5. A BRIEF COMMUNICATION ABOUT THE ANALGESIC 
PROPERTIES OF HYPERICUM EXTRACTS VIA THE TRPV1 
RECEPTOR 
 
Matthew L. Hillwig†, ‡,*, Lankun Wu†, ‡,*, and Eve Syrkin Wurtele†, ‡ 
 
Summary 
H. gentianoides has anti-inflammatory properties (Hillwig, 2008).  The bioactivity 
guided fractionation of this extract lead to the discovery that multiple acyl-phloroglucinols 
were responsible for this bioactivity (CHAPTER 3: Hillwig, in review).  One hypothesis 
generated from that previous work is pain receptors are a possible target for acyl-
phloroglucinols from Hypericum, creating a link between pain and inflammation.  There is 
increasing evidence that pain in part mediates the inflammatory responses (Fiset, 2003; 
Watkins, 2001), together with several indications that Hypericum may have analgesic 
activities (Szallasi, 2006).  This led us to investigate if Hypericum extracts affected a human 
pain receptor model system. 
Transient receptor potential vanilloid 1 (TRPV1) is a non-selective pain receptor that 
responds to different stimuli such as heat and capsaicin.  First cloned and characterized in 
1997 (Caterina, 1997), TRPV1 is involved in mediating pain and related inflammatory 
responses (Szallasi, 1999).  This non-selective pain selector is believed to be involved in 
mediating inflammatory related pain, which has made it an attractive target for drug 
development (Ferrer-Montiel, 2004).   
For initial analgesic property screening, Xenopus laevis frog oocytes transgenically 
expressing (cRNA injected) the TRPV1 human pain receptor were treated with various 
* Equal author contribution 
† Center for Research on Botanical Dietary Supplements 
‡ Department of Genetics, Development, and Cell Biology at Iowa State University 
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extracts.  Physiological studies were performed using a voltage clamp system attaching the 
cells to a circuit to measure the change in electrical current upon addition of controls and 
Hypericum extracts to the solution bathing the frog oocyte.  Those initial studies revealed 
that H. gentianoides extracts induce a TRPV1-dependent calcium ion influx (Figure 1).  
These initial findings led to more in-depth studies with human cells lines.  Transgenic human 
embryonic kidney 293T (HEK293T) cells expressing TRPV1, were treated with Hypericum 
extracts and assayed for voltage potential change in patch-clamp experiments.  Treatment of 
the HEK293T cells expressing TRPV1 with a H.  perforatum flower extract elicited a 
response (Figure 2).  Furthermore, treatment of the cells with a H. ascyron root methanol 
extract also elicited a response (Figure 3).  These results suggest that multiple metabolite 
extracts from different Hypericum species may interact directly or indirectly with the TRPV1 
receptor. 
The presence of constituents in Hypericum that alter the behavior of the TRPV1 pain 
receptor could explain analgesic effects previously observed in Hypericum species through 
classical model pain studies (Sanchez-Mateo, 2006; Rabanal, 2005). Also, molecular studies 
showing that H. perforatum extracts inhibit human inducible nitric-oxide synthase, which is 
involved in inflammatory responses (Tedeschi, 2003) that may be related to pain.   
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Figure 1.  H. gentianoides extract induces a response in TRPV1 (blue box).  Relative 
potencies of plant extracts (mean ± s.e.m., n ≥ 4 independent oocytes for each value).  
Current responses are normalized in each cell to responses obtained with capsaicin (10 µM). 
Spinach extract (0.25mg /ml) was used as control. Extracts evoked no responses in water-
injected cells. 
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Figure 2.  Hypericum perforatum flower methanol extract induces a response in 
HEK293T cells transiently expressing TRPV1 human pain receptor.  Capsaicin was 
added as a positive control for the TRPV1 receptor at 80 s. 
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Figure 3.  Hypericum ascyron root methanol extract induces a response in HEK293T 
cells transiently expressing TRPV1 human pain receptor.  Capsaicin was added as a 
positive control for the TRPV1 receptor at 80 s. 
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CHAPTER 6. DISTRIBUTION OF BIOACTIVE COMPOUNDS IN 
HYPERICUM GENTIANOIDES 
 
Matthew L. Hillwig, Eve Syrkin Wurtele. 
 
 
Introduction 
 
Like most Hypericum species, H. gentianoides has glandular structures (Figure 1). 
Their function is not fully understood although it is known that there are multiple types of 
glands and secretory canals in Hypericum, which have been shown by histochemical staining 
to accumulate different classes of metabolites (Ciccarelli, 2001).  In Hypericum perforatum 
the “light” colored glands, which appear to be perforations, accumulate the bioactive acyl-
phloroglucinol, hyperforin (Soelberg, 2007).  Also, it is known that acyl-phloroglucinols 
accumulate in Hypericum flowers during flowering prior to pollination (Abreu, 2004).  We 
are particularly interested in identifying unique morphological structures and understanding 
how acyl-phloroglucinol accumulation patterns differ throughout the inflorescence structure.  
This is particularly challenging in H. gentianoides, which to our knowledge has the smallest 
flowers of any Hypericum species (Figure 2, Figure 3). 
Materials and Methods 
 
Plants were grown from germplasm acquired from the USDA North Regional Plant 
Introduction Station, Ames, IA, accession number Ames 27629, in a greenhouse with only 
natural lighting.  Upon bolting, inflorescences were collected H. gentianoides plants.  The 
bud and first 3 nodes and internodes, from two replicates of ten stems each, were dissected 
from one another, weighed, and frozen in liquid nitrogen (Figure 4). 
The samples were then ground with a mortar and pestle under liquid nitrogen.  One 
and a half milliliters of methanol (Sigma, St. Louis) were added to the ground tissue and 
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ground for 30 s.  The methanol solution was then placed in Eppendorf tubes and incubated 
for 2 min in a 70° C water bath to deactivate enzymes and then immediately re-cooled in 
liquid nitrogen.  Samples were centrifuged at 12,000 rcf for 2 min and the methanol 
supernatant removed and filtered through 2 micron nylon syringe filters.  Samples were 
analyzed using a Beckman Coulter (Fullerton, CA) high performance liquid chromatography 
instrument with a photodiode array Detector 160 (Hillwig, 2008).  Seven peaks from the 
samples were analyzed and normalized to the weight of the individual sample; including 
three identified bioactive acyl-phloroglucinols (CHAPTER 3: Hillwig, in review), three 
suspect acyl-phloroglucinols, and one compound believed to be a sterol (Figure 5). 
Results and Discussion 
 
Figure 4 shows the morphology of the different dissected sections of the H. 
gentianoides inflorescence.  The bud region actually contains a large floral bud and much 
smaller younger floral bud.  The node region actually contains two small leaves as well.  The 
relative concentrations of 7 compounds from H. gentianoides are shown in Figure 5.   
Flower Buds 
The flower bud and the sublending nodes, which include reduced leaves, have higher 
concentrations of uliginosin A and hyperbrasilol C (Figure 6).  Two unidentified metabolites, 
tentatively indentified as acyl-phloroglucinols, at retention times 32.58 min and 33.18 min, 
are highly enriched in floral buds (Figure 5).  These metabolites may represent methylated or 
further prenylated forms of dimeric acyl-phloroglucinols based on their later retention times 
and near-identical UV absorption fingerprints (CHAPTER 1: Hillwig, 2008).   
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Nodes/Leaves 
 
Saroaspidin A does not accumulate in floral bud tissue specifically, unlike uliginosin 
A and hyperbrasilol C.  Saroaspidin A was slightly more abundant in the node/leaves section 
versus flowers.   
Internodes 
 In general, the internodes contained the lowest concentrations of all the investigated 
acyl-phloroglucinols.  This suggests acyl-phloroglucinols accumulate in leaf and floral 
structures to a greater extent than internodes.  Alternatively, the unknown sterol’s (34.37 
min) abundance was similar in all the tissues.  The relationship between compound 
accumulation and the density of glands in specific tissues is currently under investigation. 
Abbreviations Used 
HPLC=High performance liquid chromatography 
Safety 
Methanol is flammable and toxic so should be used in a fume hood. 
Acknowledgement 
 
This research was made possible by grant P01 ES012020 from the National Institute 
of Environmental Health Sciences (NIEHS) and the Office of Dietary Supplements (ODS), 
National Institutes of Health (NIH), and grant 9P50AT004155-06 from the National Center 
for Complementary and Alternative Medicine (NCCAM) and ODS, NIH. Its contents are 
solely the responsibility of the authors and do not necessarily represent the official views of 
the NIEHS, NCCAM, or NIH. 
 
 88
Literature Cited 
Abreu, I.N.; André, L.M.; Porto, L.M.; Marsaioli, A.J.; Mazzafera, P.  Distribution of 
bioactive substances from Hypericum brasiliense during plant growth.  Plant Science. 2004, 
167, 949–954. 
 
Ciccarelli, D.; Andreucci, A.C.;  Pagni, A.M.  Translucent Glands and Secretory Canals in 
Hypericum perforatum L. (Hypericaceae): Morphological, Anatomical and Histochemical 
Studies During the Course of Ontogenesis. Annals of Botany. 2001, 88, 637-644. 
 
Hillwig, M.L.; Hammer, K.D.P.; Birt, D.F.; Wurtele, E.S. Characterizing the Novel 
Metabolic Fingerprint and Anti-inflammatory Activity of Hypericum gentianoides. Journal of 
Agricultural and Food Chemistry.  2008, 56, 4359–4366. 
 
Soelberg, J.; Jorgenson, L.B.; Jager, A.K.  Hyperforin accumulates in the translucent glands 
of Hypericum perforatum. Annals of Botany. 2007, 99, 1097–1100. 
 
 
 
 
 
 
 
 89
 
 
Figure 1.  H. gentianoides leaf with translucent “light glands” highlighted. Courtesy of 
Heather Babka. 
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Figure 2. Scanning electron microscopy adaxial view of a closed H. gentianoides flower. 
Courtesy of Heather Babka. 
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Figure 3.  Comparison of flower size in six different species of Hypericum. 
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Figure 4.  H. gentianoides florescence.  This image shows the sections of the florescence 
that were dissected and collected for metabolite extraction. 
 
 
 
 
Figure 5.  Overlaid HPLC-UV chromatograph traces for the methanol extracts of the 
different tissue sections diagramed in Figure 3, pointing out the peaks of interest. 
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Figure 6.  Relative concentrations of acyl-phloroglucinols in different sections of the H. 
gentianoides bolt normalized to tissue weight (mean ± SE) (n=2). 
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CHAPTER 7. GENERAL CONCLUSIONS 
 
This dissertation has reported that extracts, fractions, and purified acyl-
phloroglucinols from H. gentianoides inhibit the synthesis of prostaglandin E2 in RAW263.7 
macrophages, modulate the TRPV1 pain receptor, inhibit the lentiviruses HIV and EIAV, 
and are cytotoxic to HeLa cancer cells.  Here, I present some insight as to possible 
mechanisms responsible for these biological activities based on my findings and the current 
literature.   
Previous reports of related dimeric acyl-phloroglucinols (DAPs), from Mallotus 
japonicus (Ishii, 2003), demonstrated that these compounds inhibit the efficiency of the 
transcription factor nuclear factor-κ B (NF-κB), in RAW263.7 macrophages by reducing its 
DNA-binding affinity.  Furthermore, these DAPs prevent the disassociation of IκB-α protein, 
which inhibits NF-κB translocation to the nucleus (Ishii, 2003).  Hence, these DAPs inhibit 
pro-inflammatory cytokine production by reducing NF- κB activation (Ishii, 2003).  
However, the DAPs from Mallotus japonicus do not contain the 3, 5-hydroxy-
cyclohexadienone (filicinic acid) structure found in the DAPs from H. gentianoides 
(CHAPTER 3, Figure 10).  
Modulation of Redoxins by Acyl-phloroglucinols and the Impact on NF-κB Activation 
Redox state modulates many aspects of cellular metabolism and signaling, including 
the expression of tumor necrosis factor-alpha (TNF-α), which is activated by NF-κB 
(Haddard, 2002) and is known to modulate cell-cycle state (Aggarwal, 2000).  HeLa cells are 
highly sensitive to apoptosis when treated with acyl-phloroglucinols from H. gentianoides 
(Chapter 3).  Evidence in the literature supports the working hypothesis that certain acyl-
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phloroglucinols are acting on key cellular processes of the cell directly responsible for redox-
state regulation (Verotta, 2002).  Acyl-phloroglucinols can act as both antioxidants and pro-
oxidants, via C-centered and O-centered radical formation, as first noted for polyprenylated 
acyl-phloroglucinols by Verotta (2002). The proposed mechanism for these states in the anti-
inflammatory DAP, saroaspidin A, is shown below. 
 
Figure 1.  Proposed C-radical and O-radical states for saroaspidin A.  This would allow 
DAPs such as saroaspidin A to act as an antioxidant or pro-oxidant depending on the 
environment. 
 
The findings that redox state plays an important role in regulating NF-κB (Wang, 
2008) may explain the connection between anti-inflammatory acyl-phloroglucinols, such as 
hyperforin, and its induction of apoptosis in cancer cells via up-regulation of caspase-3 
(Quiney, 2006).  It is known that the redox state of cells can act as a regulator between 
continued cell cycles and programmed cell death, as demonstrated in astrocytes (Smith, 
2000).  Furthermore, the up-regulation of thioredoxins decreases NF-κB activation, while up-
regulation of nucleoredoxin and glutaredoxin increases NF-κB activation (Hirota, 2000).  
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The up-regulation of thioredoxin 2 prevented TNF- α induced programmed cell death 
(Hansen, 2006).  Hence, alteration of certain redoxins by acyl-phloroglucinols, such as 
hyperforin and saroaspidin A, may be the underlying cause of the observed reduction of 
interleukins and/or prostaglandins, whose biosynthesis is dependent in part on NF-κB 
activation.  Redoxins are an attractive target for new drug-discovery research, since 
inhibition and activation of certain redoxins, particularly thioredoxins, could reduce 
inflammatory responses inducing apoptosis of cancer cells, and inhibit viral replication via 
modulating NF-κB activation (Sakurai, 2003).  A proposed mechanism is shown in Figure 2. 
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Figure 2. Proposed mechanism for acyl-phloroglucinols inhibiting NF-κB activation via the 
inhibition of IκB-α kinase by alteration of thioredoxin redox state.  Furthermore, acyl-
phloroglucinols could alter HIV protein Tat function, via this same signaling pathway, by 
altering the affect of increased reactive oxygen species production. 
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HIV alters the redox state of cells mainly through Tat and/or gp160, which enhance 
oxidative stress (Lachgar, 1999), to aid in its replication by inducing the expression of 
cytokine TNF-α, which induces the activation of NF-κB (Westendorp, 1995).   Related 
studies in H. perforatum demonstrate that TNF-α can be down-regulated by specific 
concentrations of a combination of 4 compounds, supporting the suppression of NF-κB 
activity as the cause of COX-2 down-regulation (Appendix A: Hammer, 2008).  This further 
supports the hypothesis that there is a connection between the anti-inflammatory activity, 
anti-viral properties, and anti-proliferative activity caused by acyl-phloroglucinols (Figure 2). 
Nuclear Receptors as Targets for Acyl-phloroglucinols 
Another possible mechanism is proposed for these bioactive DAPs.  Shay et al. 
(2005) suggested that “promiscuous” nuclear receptors may represent such a target for other 
types of acyl-phloroglucinols.  Hyperforin, from St. John’s wort, represents an example of an 
acyl-phloroglucinol that binds to a nuclear receptor.  Hyperforin binds to pregnane X, a 
nuclear receptor responsible for up-regulated expression of mammalian cytochrome P450 
enzymes (Moore, 2000).  The existence of other nuclear receptors that DAPs bind to could 
explain the modulation of transcription factors such as NF-kB when cells are treated with 
certain phloroglucinols, and there are numerous putative nuclear receptors with no known 
ligand (Shay, 2005) that may represent these regulators for specific cellular processes such as 
maintaining redox state.  Furthermore, altering redox state changes the function of nuclear 
receptors, as shown for estrogen receptors (Hayashi, 1997).   
TRPV1 Receptor as a Target for Acyl-phloroglucinols 
Our findings show that multiple Hypericum extracts alter the physiology of TRPV1 
human pain receptors, inducing calcium influx.  Recently, it has been recognized that the 
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transient receptor potential vanilloid 1 (TRPV1) receptor represents far more then a target for 
treating pain perception (Szallasi, 2006).  This is an emerging research area with far more 
questions than answers, currently.  There are many small molecules that bind with TRPV1.  
Novel ligands for TRPV1 receptors have been identified, including polyunsaturated fatty 
acids (Matta, 2007).  There may be other small-molecules, which bind to TRPV1 receptors.  
The transmission of perceived pain signals are often mediated by excreted molecules 
from other cell types that are ligands for neural receptors (Fiset, 2003; Watkins, 2001).   
These examples provide evidence as to why receptors such as TRPV1 may have multiple 
native ligands that bind to and alter the behavior of the ion channel.  The further investigation 
of Hypericum metabolites such as acyl-phloroglucinols may provide insight about what type 
of native ligands may bind to TRPV1. 
Hypericum secondary/specialized metabolites provide a potential source for future 
drug discovery and offer insights in to the chemical ecology between organisms; particularly 
acyl-phloroglucinols.  We show that multiple biosynthetically related acyl-phloroglucinols 
have biological activity in mammalian cells.  The multiple bioactivities of these related acyl-
phloroglucinols suggest a coordinated mechanism to modulate the state of other organisms’ 
cellular processes.  First, they are altering inflammatory signaling pathways sensitive to 
redox changes in the cell.  Secondly, there is a physiological effect on TRPV1, but the 
connection is unknown. The continued working hypothesis is that plants evolved complex 
biochemically related acyl-phloroglucinols to modulate other organisms, such as pathogens, 
by altering redox state and signaling-receptor pathways. 
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Abstract 
Hypericum perforatum (Hp) has been used medicinally to treat a variety of conditions 
including mild-to-moderate depression. Recently, several anti-inflammatory activities of Hp 
have been reported.  An ethanol extract of Hp was fractionated with the guidance of an anti-
inflammatory bioassay (lipopolysaccharide (LPS)-induced prostaglandin E2 production 
(PGE2)), and four constituents were identified.  When combined together at concentrations 
detected in the Hp fraction to make a 4 component system, these constituents (0.1 µM 
chlorogenic acid, 0.08 µM amentoflavone, 0.07 µM quercetin, and 0.03 µM 
pseudohypericin) explained the majority of the activity of the fraction when activated by 
light, but only partially explained the activity of this Hp fraction in dark conditions.  One of 
the constituents, light-activated pseudohypericin, was necessary, but not sufficient to explain 
the reduction in LPS-induced PGE2 of the 4 component system.  The Hp fraction and the 4 
component system inhibited lipoxygenase and cytosolic phospholipase A2, two enzymes in 
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the PGE2-mediated inflammatory response.   The 4 component system inhibited the 
production of the pro-inflammatory cytokine tumor necrosis factor-α (TNF-α), and the Hp 
fraction inhibited the anti-inflammatory cytokine interleukin-10 (IL-10).  Thus, the Hp 
fraction and selected constituents from this fraction showed evidence of blocking pro-
inflammatory mediators but not enhancing inflammation-suppressing mediators.   
Keyword Index 
Hypericum perforatum, anti-inflammatory, Prostaglandin E2, RAW 264.7, pseudohypericin, 
flavonoids  
Introduction 
The synthesis of prostaglandins plays a critical role in normal physiological processes 
as well as acute and chronic inflammatory states (Dubois et al., 1998; Portanova et al., 1996) 
and the key enzymes involved in prostaglandin biosynthesis are prostaglandin endoperoxide 
synthases, also known as cyclooxygenases.  Cyclooxygenase-1 (COX-1) is responsible for 
housekeeping functions such as maintenance of gastric mucosa (Smith et al., 1996).  
Cyclooxygenase-2 (COX-2) is induced by lipopolysaccharide (LPS) to produce 
prostaglandins, of which prostaglandin E2 (PGE2) is one of the main mediators of 
inflammation (Minghetti et al., 1999; O’Sullivan et al., 1992).  Cytosolic phospholipase A2 
(cPLA2) releases arachidonic acid, the substrate for COX and lipoxygenase (LOX) enzymes, 
from membrane phospholipids.   
Cytokines mediate the inflammatory response in a complex manner, during its early, 
middle, and late stages.  Tumor necrosis factor-α (TNF-α), an early pro-inflammatory 
cytokine, is involved in the pathogenesis of many inflammatory diseases and can regulate the 
growth, proliferation, and viability of leukocytes (Aggarwal, 2000; Calamia, 2003).  
 102
Interleukin-10 (IL-10), an anti-inflammatory cytokine predominant in the later phases of 
inflammation, is a potent inhibitor of macrophage function, and IL-10 can block the synthesis 
of TNF-α and can inhibit COX-2 induction (Niiro et al., 1995; de Waal-Malefyt et al., 1991).  
Preparations that can modulate one or many of the mediators of inflammation may be useful 
for the treatment of inflammatory diseases.   
Hypericum perforatum (Hp) contains unusual compounds such as hypericin, 
pseudohypericin, and hyperforin, as well as compounds present throughout the plant 
kingdom (Bilia et al., 2002).  Raso et al. (2002) found that giving 100 mg/kg of Hp extract by 
gavage to mice two times daily significantly reduced COX-2 protein levels in peritoneal 
macrophages.  Hp extracts and many of the constituents in these extracts (light-activated 
pseudohypericin, flavonoid compounds, hyperforin) reduced LPS-induced PGE2 production 
in RAW 264.7 macrophages (Hammer et al., 2007).    Furthermore, Hp extracts exhibited 
light-independent reductions in LPS-induced PGE2, but pseudohypericin significantly 
decreased LPS-induced PGE2 at 1 and 2 µM only in light-activated conditions and 20 µM 
hypericin increased PGE2 with and without LPS only in light-activated conditions.   This data 
established that although individual constituents like pseudohypericin and hypericin needed 
activation by light to produce an effect on PGE2, confirming previously reported light-
activated bioactivities of hypericin (Bilia et al., 2002; Carpenter et al., 1991), Hp extracts did 
not differ in light-activated and dark conditions, contrary to previously reported bioactivities 
(Bilia et al., 2002; Schmitt et al., 2006a; Schmitt et al., 2006b). Other compounds like the 
flavonoids and caffeic acid derivatives did not differ in light-activated and dark treatments 
(Hammer et al., 2007).  It is vital to understand the effects of isolated active constituents as 
well as combinations of active constituents to relate the bioactivity of the constituents to the 
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bioactivity of extracts (Spinella, 2002).   Of 10 potentially bioactive constituents tested, only 
the concentration of pseudohypericin detected in the Hp extracts (0.2 to 1 µM) was above the 
level of pure constituent (1 µM) needed to observe a significant reduction in PGE2 production 
in RAW 264.7 mouse macrophages (Hammer et al., 2007).  However, pseudohypericin’s 
presence in the extracts did not appear to account for the activity of the extracts, suggesting 
that the interactions of the constituents may be important (Hammer et al., 2007).  
Bioactivity-guided fractionation was used to identify constituents present in an Hp 
ethanol extract that may be responsible for anti-inflammatory activity of the extract.  Our 
hypothesis was that flavonoid compounds were contributing to the anti-inflammatory activity 
of the Hp extracts, along with other constituents that may interact with the flavonoids.  To 
test this hypothesis, we used a strategy intended to enrich the fractions in flavonoids, and 
evaluated the fractions for a reduction in LPS-induced PGE2 production.  To compare our 
anti-inflammatory results to a known compound, we used concentrations of quercetin 
exceeding the levels found in Hp extracts and that have previously been shown to inhibit 
inflammatory endpoints of interest as a positive control.   
Results/Discussion 
The bioactivities of Hp fractions from four rounds of iterative fractionations are 
presented in Table 1.  The original Hp ethanolic extract significantly inhibited LPS-induced 
PGE2 production in RAW 264.7 mouse macrophages at both 10 and 20 µg/ml.  There was a 
significant reduction in cell viability associated with the 20 µg/ml dose of the Hp extract, 
although the reduction in PGE2 (46% of PGE2 control) could not be fully explained by this 
decreased cell viability data (58% of cell viability control).  This original Hp extract was 
fractionated using ethanol, chloroform, or hexane into three fractions (1A: ethanol, 1B: 
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hexane, and 1C: chloroform).  The most active fraction from the first round of fractionation 
at 10 µg/ml was fraction 1C when compared with other fractions; 36% of the PGE2 
production compared to control and 74% of cell viability compared to control.  
Subfractionation of fraction 1C by column chromatography with a solvent series of 
chloroform (CHCl3), acetonitrile (CH3CN), and methanol (MeOH) led to 4 fractions (2A, 2B, 
2C, 2D), of which, 10 µg/ml of fraction 2C most significantly decreased PGE2 as compared 
to control (44% of PGE2 control, 96% of cell viability control) and was the most active of the 
second round fractions at 10 µg/ml.  Fraction 2C was further sub-fractionated using column 
chromatography with 1:1 CH3CN:CHCl3 to 1:1 MeOH: CH3CN (3A, 3B, 3C, 3D, 3E, 3F).  
Of the third round fractions, fraction 3A significantly decreased PGE2 (22% of PGE2 control, 
85% of cell viability control) at a concentration as low as 10 µg/ml.  Fraction 3A was further 
sub-fractionated using column chromatography with a step gradient from 10% 
CH3CN:CHCl3 to 100% MeOH into 7 fractions (4A, 4B, 4C, 4D, 4E, 4F, 4G).  The most 
active fraction from the last round of fractionation was fraction 4F (58% of PGE2 control, 
101% of cell viability control) at 2 µg/ml; however, the reduction in PGE2 was not 
statistically significant.    
The concentrations of 10 constituents were quantified in the original Hp extract and 
the four most active fractions (1C, 2C, 3A, 4F) are shown in Table 2.  The most abundant 
constituents in the original Hp extract were hyperforin (12.5 µM), chlorogenic acid (6.1 µM), 
rutin (2.7 µM), and hyperoside (1.6 µM) (Table 2).  After the first round of fractionation, the 
concentrations of all the constituents in fraction 1C were at or below 1 µM.  It is possible that 
agents that suppressed the inhibition of PGE2 production were removed in the earlier stages 
of fractionation since the concentration of putative active constituents decreased successively 
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from the extract to fraction 1C and then to fraction 2C.  In addition, unknowns comprised a 
larger portion of the later subfractions because the concentration of constituents decreased as 
the fractionation progressed, although activity remained about the same and was even greater 
from fraction 2C to 3A. The ratios of the 4 putative bioactive constituents in the fraction 
seemed to follow the pattern: greatest amount of chlorogenic acid, followed by roughly equal 
amounts of quercetin and amentoflavone, and the least amount of pseudohypericin (Table 2 
figure legend).  Ratio analysis of the levels of the four constituents in the extract and active 
fractions suggested that the greatest activity was obtained when the levels of chlorogenic 
acid, quercetin, and amentoflavone were approximately the same and that these 
concentrations were two to three times higher than pseudohypericin, as seen with fraction 
3A.  Additionally, the lowest activity was seen when only chlorogenic acid and 
pseudohypericin were detected, as seen with fraction 4F.   Although compounds such as 
hypericin may have non-reversibly adsorbed to the silica gel column, results from the PGE2 
assay confirmed that at least one fraction was active from each round as the fractionation 
progressed.  Additionally, flavonoids were compounds of particular interest in this 
fractionation and in previous studies, hypericin was shown to increase PGE2 production in 
LPS-induced RAW 264.7 mouse macrophages (Hammer et al., 2007). 
Since fraction 3A was significantly active in the PGE2 assay and from the later rounds 
of fractionation, experiments were conducted to determine if combining its putative bioactive 
constituents (chlorogenic acid, amentoflavone, quercetin, and pseudohypericin) into a 4 
component system at the amount detected in fraction 3A could explain the reduction in PGE2 
by fraction 3A.  These constituents were also studied together as a 4 component system at ten 
times and one hundred times the amount detected in fraction 3A.  None of the four 
 106
constituents alone reduced PGE2 in light-activated or dark conditions (Table 3).  
Combinations of the four constituents revealed that combinations without pseudohypericin 
were not effective at reducing PGE2.  Two-way and three-way combinations with 
pseudohypericin seemed to explain some of the light-activated activity of the Hp fraction, 
however; not to as great of an extent as the 4 component system. The combination of all four 
constituents (34% of PGE2 control, 101% of cell viability control) was sufficient to explain 
the anti-inflammatory activity of fraction 3A (12% of PGE2 control, 85% of cell viability 
control) in light-activated conditions. Furthermore, this combination of constituents was even 
more effective at reducing PGE2 in light-activated than dark conditions.  Hyperforin and 
hypericin were not added to the 4 component system because they were only detected in the 
fraction and were not able to be quantified using standard curves of the pure compound.  
However, later experiments determined that adding 0.01 µM or 0.001 µM hyperforin to the 4 
component system did not change the reduction in PGE2 associated with the system (data not 
shown) and hypericin increased the production of PGE2 and had significant cytotoxicity 
associated with low doses in the RAW 264.7 macrophage cells (Hammer et al., 2007).  Thus, 
the 4 component system explained the light-activated activity of the Hp fraction but not the 
dark activity and pseudohypericin was necessary for the light-activated activity. 
Since the four constituents together seemed to best account for the reductions in PGE2 
of the fraction, further explorations compared only the 4 component system with the Hp 
fraction to determine if comparable synergy existed in other endpoints.  To assess the 
reduction in PGE2 associated with fraction 3A and the 4 component system, COX-1 and 
COX-2 protein levels (Figure 1) and enzyme activities (Figure 2) were examined.  LPS-
treated groups are shown in Figure 1 and treatments without LPS are described in the legend 
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for COX-1 and COX-2 protein levels.  No change in COX-1 protein level was detected 
among treatments without the addition of LPS and COX-1 protein levels were 
indistinguishable in the LPS and non-LPS treated controls.   No change in COX-1 protein 
level was detected with the fractions or 4 component system when LPS was added (Figures 
1a and 1b).   COX-2 protein level was increased with the addition of LPS to the culture 
media and there was no change in COX-2 protein level when the treatments were added 
without LPS (Figure 1).  The positive control, 100 µM quercetin, significantly decreased the 
LPS-induced COX-2 protein level, as described in the Figure 1 legend.  COX-2 protein was 
reduced when fraction 3A and 100x the 4 component system were included in light-activated 
conditions (Figured 1a and 1c), but not in dark treatment conditions (Figure 1 legend).  
Fractions 1C and 2C did not reduce LPS-induced COX-2 protein levels in light-activated 
conditions (Figures 1a and 1c), further confirming the PGE2 data showing that fraction 3A 
was the most anti-inflammatory among the active fractions. 
Consistent with the lack of induction of COX-1 protein, no change in COX-1 activity 
was detected with fraction 3A or the 4 component system (Figure 2a).  In contrast, fraction 
3A significantly decreased COX-2 activity as compared to media + LPS + DMSO control in 
both light-activated and dark conditions, whereas the 4 component system significantly 
decreased COX-2 activity only in light-activated conditions (Figure 2b).  The positive 
control, 25 µM quercetin, significantly reduced COX-2 activity (Figure 2b).  COX-2 activity 
was similar among treatments without LPS (Figure 2b).    
To further assess the breadth of anti-inflammatory capabilities of fraction 3A and to 
compare the activity of the Hp fraction with the activity of the 4 component system, we 
examined cPLA2 activity and lipoxygenase inhibition, as well as TNF-α and IL-10 
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production in the RAW 264.7 macrophage cells.  The positive control, 25 µM quercetin, 
significantly reduced LPS-induced cPLA2 and lipoxygenase activity (Figures 3a and 3b). 
Fraction 3A decreased LPS-induced cPLA2 activity as compared to the control in both light-
activated and dark conditions, but the 4 component system significantly decreased LPS-
induced cPLA2 activity only in light-activated conditions (Figure 3a).  The light-activated 4 
component system displayed similar lipoxygenase inhibitory activity as fraction 3A, and 
there was no significant difference between light-activated and dark conditions for either 
treatment (Figure 3b).  Fraction 3A did not reduce the pro-inflammatory cytokine TNF-α at 
either 8 or 24 hours, nor did the 4 component system at 8 hours (Figures 4a and 4b).  The 4 
component system significantly reduced TNF-α at 24 hours in the light (Figure 4b).  The 
levels of the anti-inflammatory cytokine IL-10 were reduced by fraction 3A at both 8 and 24 
hours in light-activated and dark conditions (Figure 5a and 5b).  Only the light-activated 4 
component system did not significantly inhibit the anti-inflammatory cytokine IL-10 at 8 and 
24 hours, although the level of IL-10 was not sustained at the level of the media + LPS + 
DMSO control.  The complexity of this data suggests that perhaps the 4 component system 
and fraction 3A affect prostaglandin biosynthesis pathways in similar ways, but not the 
production of IL-10 and TNF-α, two cytokines important in inflammation. 
 The most intriguing observations from these experiments are that the combination of 
chlorogenic acid, amentoflavone, quercetin, and pseudohypericin, at their respective 
concentrations in fraction 3A, explained the light-activated inhibition of LPS-induced PGE2 
production by fraction 3A and that pseudohypericin was necessary for the activity of 4 
component system.  However, 1 µM light-activated pure pseudohypericin was required to 
significantly reduce PGE2 (Hammer et al., 2007) and pure pseudohypericin at 0.03 µM did 
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not reduce PGE2. In previous studies, greater than 5 µM quercetin and 10 µM amentoflavone 
were required to significantly reduce PGE2, and chlorogenic acid up to 40 µM did not reduce 
PGE2 by itself (Hammer et al, 2007).    Since one or more of these constituents were needed 
in addition to pseudohypericin in combination experiments to effectively reduce PGE2, we 
postulated that the synergistic interactions among these constituents were important in the 
RAW 264.7 macrophages and that pseudohypericin was necessary, but not sufficient for the 
light-activated anti-inflammatory activity.  Notably, the 4 component system did not explain 
the activity of fraction 3A in the dark. 
Synergistic interactions have previously been described for the anti-depressant 
activities of constituents present in Hp extracts, although light conditions were not controlled.  
In the forced swimming test model of anti-depressant activity, a fraction of procyanidins was 
not active alone, but was significantly active when pseudohypericin and hypericin were 
added (Butterweck et al., 1998).  Interestingly, procyanidins increased the water solubility of 
hypericin up to 400 fold (Juergenliemk, 2003a).  When the flavonoid rutin, which was 
inactive in the forced swimming test alone, was combined with inactive Hp extracts, there 
was a strong anti-depressant effect (Noeldner and Schotz, 2002).  The present report is 
perhaps the first identification of interactions of constituents in Hp necessary for an anti-
inflammatory activity of an Hp extract.   
The reduction by Hp of PGE2 and COX-2 protein levels confirms that the eicosanoid 
pathway may be an important pathway for the anti-inflammatory activity of Hp. The Hp 
fraction 3A and the 4 component system inhibited cPLA2 activity, which could limit the 
amount of arachidonic acid available to the COX-2 enzyme.  Both the Hp fraction and 4 
component system also inhibited lipoxygenase activity.  Limiting arachidonic acid would 
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also limit the availability of the substrate to the lipoxygenase enzymes.  Future studies could 
explore if products of lipoxygenases such as lipoxins or leukotrienes are also affected by 
these treatments.   
The light-activated 4 component system reduced the pro-inflammatory cytokine TNF-
α at 24 hours and the 4 component system in the dark treatment condition inhibited the anti-
inflammatory cytokine IL-10 at both 8 and 24 hours.  The Hp fraction inhibited IL-10 
production at both time points examined, but not TNF-α production.    Since TNF-α would be 
produced early in the inflammatory process and perhaps at the same time as PGE2, select 
bioactive constituents may act in the early phases of inflammation.  Therefore, Hp or select 
constituents may decrease pro-inflammatory mediators, but not increase mediators involved 
in suppressing inflammation at later stages.  Also, the light-activated 4 component system did 
not significantly inhibit IL-10, but the IL-10 level was not sustained at the level of the 
control, suggesting that the bioactive constituents may impact pro-inflammatory mediators 
more than anti-inflammatory mediators.  However, the modulation of cytokines and other 
mediators in inflammation is complex.   
Data on the bioavailability of constituents shown to be responsible for a given 
bioactivity is also critical for predicting in vivo effects and the synergistic interactions of the 
constituents might be important for bioavailability.  Murota et al. (2000) showed that 
quercetin glucosides were capable of passing through the Caco-2 epithelial cell monolayer, 
but their efficiency was lower than the aglycone quercetin.  The bioavailability of 
pseudohypericin might be increased by the presence of the flavonoid quercetin and/or 
biflavonoid amentoflavone, since the oral bioavailability of hypericin, which has a structure 
very similar to pseudohypericin, was increased by 34% with the addition of the flavonoid 
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hyperoside in rats (Butterweck et al., 2003).  Hyperoside  increased the water solubility of 
hypericin by 58% in vitro using the octanol/water partition coefficient (Juergenliemk, 
2003a).  Further, a metabolite of orally ingested quercetin, miquelianin, was able to cross 
small intestine and central nervous system barriers in vitro (Juergenliemk et al., 2003b), 
suggesting that quercetin metabolites might not only enhance bioavailability of other 
compounds, but might have considerable bioactivity alone. 
Besides increased bioavailability, other plausible explanations to consider are that 
compounds from the 4 component system may alter the production of reactive oxygen 
species (ROS), reduce the light-activation of pseudohypericin, or affect electron transport, all 
processes which may affect the light-activated cytotoxicity of hypericin or pseudohypericin.  
Data concerning these processes are very limited for pseudohypericin, however, the light-
activation and subsequent effects of hypericin have been well documented.  There is also 
data available concerning other compounds found in Hp. Quercetin has been shown to be a 
strong singlet oxygen quencher and have anti-oxidant properties (Tournaire et al., 1993; 
Korkina and Afanasev, 1997). Quercetin (10 µM) had a significant protective effect against 
cytotoxicity of 10 µM hypericin in HL-60 promyelocytic cells, most likely by reducing ROS 
(Mirossay et al., 2001).  Chlorogenic acid (10 µM) attenuated the cytotoxicity of 20 µM 
hypericin in HaCat human keratinocytes (Schmitt et al, 2007b).  Couladis et al. (2002) tested 
an Hypericum triquetrifolium Turra extract for anti-oxidant activity.  Interestingly, four 
constituents were identified that were present within the extract; quercetin, rutin, chlorogenic 
acid, and amentoflavone, and each constituent possessed anti-oxidant activity.  The 
antioxidant activity of amentoflavone was similar to the α-tocopherol positive control, 
whereas the other constituents possessed less anti-oxidant activity.  It is plausible that 
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quercetin, chlorogenic acid, and amentoflavone may play a role in lessening ROS damage 
from pseudohypericin.  Perhaps a combination of enhanced bioavailability and other 
mechanisms like decreased ROS production or reduced light-activation or electron transfer 
may aid the synergistic interactions of constituents to produce a 4 component system with 
comparable light-activated anti-inflammatory activity to the Hp fraction. 
Conclusions and Concluding Remarks 
An anti-inflammatory bioactivity-guided fractionation of an Hp extract led to the 
identification of four constituents (chlorogenic acid, amentoflavone, quercetin, and 
pseudohypericin) that in concert explained the reduction in LPS-induced PGE2 of an Hp 
subfraction in light-activated conditions.  Pseudohypericin was necessary but not sufficient 
for the reduction in LPS-induced PGE2.  The data presented here and current literature 
supports that the Hp fraction exerts effects on COX-2 and upstream mediators.  These data 
highlight the possibility that unknown and/or unidentified compounds contribute 
significantly to the activity of fraction 3A in the dark.  These experiments verify the need for 
more data on the synergistic interactions of constituents present in botanical extracts and 
their interactive roles in bioactivity. 
Experimental 
General Experimental procedures 
Cell culture: RAW 264.7 mouse macrophages were purchased from the American Type 
Culture Collections (ATCC; Manassas, VA) and cultured as previously described (Hammer 
et al., 2007).  Treatments for the PGE2 and cell viability assays were performed as previously 
described (Hammer et al., 2007).   The assays were always performed in both light-activated 
and dark conditions, because the naphthodianthrones present within Hp extracts display well-
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described light-activated properties.  Details on the light-activation and dark treatments were 
previously published in Schmitt et al. (2006a).  
PGE2 and Cytotoxicity Assays:  Samples were assayed with a Prostaglandin E2 EIA kit (GE 
Biosciences, Piscataway, NJ) or CellTiter96® Aqueous One Solution cell proliferation assay 
(Promega Corporation, Madison, WI) as previously described (Hammer et al., 2007). 
COX activity assay:  The COX activity assay was used according to manufacturer’s 
instructions (Cayman Chemicals; Ann Arbor, MI).  The kit measures the peroxidase activity 
of cyclooxygenase colorimetrically by addition of arachidonic acid and monitoring the 
appearance of oxidized N’, N’, N’, N’-tetramethyl-p-phenylenediamine (TMPD) at 590 nm. 
Quercetin (25 µM) was used as a positive control to demonstrate inhibition of COX-2 
activity because Al-Fayez showed the 50% inhibitory dose of quercetin was 5 µM (Al-Fayez 
et al., 2006). 
cPLA2 and Lipoxygenase Inhibitory Assays :  Cells were plated in petri dishes and allowed to 
attach for 24 hours.  Cells were treated with or without fraction or constituent and with or 
without LPS for 8 hours and further processed as described by the manufacturer.  Activity 
was measured using the cPLA2 assay kit or the lipoxygenase inhibitor screening assay kit 
(both Cayman Chemical Company; Ann Arbor, MI).  Quercetin (25 µM) was used as a 
positive control to demonstrate inhibition of cPLA2 and lipoxygenase because Lindahl and 
Tagesson (1993) showed quercetin less than 100 µM inhibited cPLA2 activity and Deng et al. 
(2007) showed that quercetin inhibited 50% of 5-LO and 15-LO at 5.9 and 0.52 µM, 
respectively. 
TNF-α and IL-10 Assays:  Cells were treated as previously described (Hammer et al., 2007) 
and supernatants were collected on ice and frozen at -70° C until assayed using a TNF-α and 
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IL-10 mouse ELISA plate (BD Biosciences Pharmingen, San Diego, CA) with methods 
described by the manufacturer and similar to Senchina et al. (2007).  Quercetin (25 µM) was 
used as a positive control to demonstrate inhibition of TNF-α and increase in IL-10 because 
Comalada et al. (2006) showed that quercetin decreased TNF-α production (50% inhibitory 
dose was 20 µM) and 25 quercetin increased IL-10 production in bone marrow-derived 
macrophages. 
Western Blotting:  After an 8 hour treatment, cells were rinsed twice with cold 1X phosphate 
buffered saline (PBS).  Lysis buffer (50 mM Tris-hydrochloride, 2 mM ethylenediamine 
tetraacetic acid, 2 mM ethylene glycol tetraacetic acid, 150 mM sodium chloride, 2 mM 
phenylmethanesulphonylfluoride, 25 mM leupeptin, 10 mM aprotinin, 10 mM sodium 
fluoride, 10 mM sodium orthovanadate, 10 mM sodium pyrophosphate, 0.5% Triton X-100) 
was added to the dishes on ice and the cells were dissociated from the plate by scraping.  The 
lysate was centrifuged at 4° C, and the supernatant was removed.  The protein concentration 
in each lysate was determined using the bicinchonic acid and copper sulfate protein assay 
(Sigma; St. Louis, MO).  Western blot separation and detection was used as previously 
described (Przybyszewski et al., 2001).  COX-1 and COX-2 rabbit polyclonal antibodies 
(Santa Cruz Biotechnology; Santa Cruz, CA) were diluted 1:1000 in 5% milk Tris buffered 
saline with 0.5% Tween-20.  Semi-quantitative representation was achieved by using the 
ImageQuaNT program.  Three replicates of each treatment were analyzed on separate blots.  
Blots were normalized for consistency by using a repeat control present on each blot.  
Quercetin (100 µM) was used as a positive control to demonstrate reduction in COX-2 
protein level because Raso et al. (2002) showed 50 µM quercetin decreased COX-2 protein 
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in J774A.1 macrophages.  Quercetin was not shown on the blots to facilitate comparisons 
among the graphs, however; the values for quercetin are given in the figure legend. 
Compound Identification and Quantification using LC-MS-UV Analysis:  An Agilent 
Technologies 100 Ion Trap Liquid Chromatography- Electron Spray Ionization-Mass 
Spectrometer, with a coupled UV absorption detector (LC-MS-UV) was used for 
quantification of compounds, as previously described (Hammer et al., 2007).  Specifically, 
ten compounds were identified based on the availability of standards and identification in a 
previous publication (Hammer et al., 2007).  Compounds identified were: chlorogenic acid, 
rutin, hyperoside, isoquercitrin, quercitrin, quercetin, amentoflavone, pseudohypericin, 
hypericin, and hyperforin (Juergenliemk and Nahrstedt, 2001; Williams et al., 2006).   Each 
standard was run on the LC-MS. The peaks from the Hp fractions were confirmed by 
evaluating the retention time and mass spectra of each peak with the retention time and mass 
spectra for the standard of interest.  Stock solutions of each extract or subfraction were: 20 
mg/ml for extract, 10 mg/ml for fraction 1C, 40 mg/ml for fraction 2C, 10 mg/ml for fraction 
3A, and 0.7 mg/ml for fraction 4F.    
Statistical Analysis:  The COX activity, cPLA2, lipoxygenase, TNF-α, IL-10, and protein 
data were logarithmically transformed to eliminate unequal variances and skewed 
distribution and an F-protected two-way ANOVA was used followed by a Tukey-Kramer test 
for multiple comparisons for all samples (Snedecor and Cochran, 1989).  The PGE2, 
cytotoxicity, light versus dark treatments, and LC-MS-UV data were analyzed as previously 
described (Hammer et al., 2007).   P-values  0.05 were considered statistically significant.   
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Documentation of plants   
One accession of Hp, the commercial variety Common, was provided by the North 
Central Regional Plant Introduction Station (NCRPIS; Ames, IA).  Plant material was 
harvested in July 2004 from plants cultivated on site and processed as previously described 
(Schmitt et al., 2006).  Dried Hp plant material (108 grams; aerial parts) was extracted by 
Soxhlet extraction for 6 hours with 95% ethanol and yielded 38 grams of dry residue. Two 
grams of dry residue was dissolved in 10 mls dimethylsulfoxide (DMSO) (Sigma; St. Louis, 
MO) for the PGE2 screening of the original extract.   
For fractionation, the residue from an ethanol extract of Hp (36 g) was dissolved in 
10% aqueous ethanol (1100 mL) and extracted with hexanes (300 mL).    After the ethanol 
solution was extracted with CHCl3 (500 mL), all three fractions (1A, 1B, 1C) were 
concentrated in vacuo.  Samples of the resulting residues were tested for activity, and only 
the CHCl3 fraction (1C) displayed significant reduction in PGE2. 
The residue from fraction 1C (3.1 g) was dissolved in a minimum volume of CHCl3 
and further purified by normal phase column chromatography on silica gel.  Silica gel was 
chosen as a support for column chromatography to maximize the separation efficiency, even 
though the potential for non-reversible adsorption was recognized.  Elution with a solvent 
series consisting of CHCl3 (375 mL), a 1:1 mixture of CHCl3:CH3CN (475 mL), CH3CN 
(450 mL), and finally a 1:1 mixture of CH3CN:MeOH (500 mL) afforded four fractions  (2A, 
132 mg; 2B, 1.01 mg; 2C, 158 mg; and 2D,  951 mg; respectively) for a total recovery of 
73%.  After concentration in vacuo, bioassays of the four fractions identified fraction 2C as 
the most active and 2C was further purified by column chromatography on silica gel.  A 
solvent step gradient from 1:1 CH3CN:CHCl3 to 1:1 MeOH:CH3CN  afforded 6 fractions, 
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(3A, 1:1 CH3CN:CHCl3, 70 mL, 35.4 mg;  3B,  1:1 CH3CN:CHCl3, 70 mL, 61.5 mg; 3C, 
1.5:1 CH3CN:CHCl3, 135 mL, 16.1 mg; 3D, 3:1 CH3CN:CHCl3, 100 mL, then 100% 
CH3CN, 100 mL, 5.2 mg; 3E, 1:9 MeOH:CH3CN, 100 mL, then 1:5 MeOH:CH3CN, 100 
mL, 21.6 mg;  and finally 3F, 1:1 MeOH:CH3CN, 100 mL, 7.7 mg, respectively, representing 
99% recovery).    The fraction that displayed the most significant activity, fraction 3A, was 
finally purified by column chromatography on silica gel.  This fraction (34 mg) was placed 
on a column of silica gel (0.5 by 14 cm) and eluted with a step gradient from 10% 
CH3CN:CHCl3 to 100% MeOH to give the final 7 fractions 4A-G (4A, 1:9 CH3CN:CHCl3, 
100 mL, 6.2 mg; 4B, 1:9 CH3CN:CHCl3, 75 mL, 8.7 mg; 4C, 1:3 CH3CN:CHCl3, 75 mL, 
12.6 mg; 4D, 1:1 CH3CN:CHCl3, 75 mL, then 3:1 CH3CN:CHCl3, 75 mL, 4.9 mg; 4E, 1:5 
CH3CN:CHCl3, 20 mL, 3.8 mg; 4F, 1:5 MeOH:CH3CN, 50 mL, 1.4 mg; and 4G, 100% 
MeOH, 100 mL, 3.4 mg).   
Endotoxin levels of the extracts were assayed as previously described (Hammer et al., 
2007) to confirm that endotoxin present in the extracts did not affect PGE2 levels.   The range 
of endotoxin levels present was 0.000003 to 0.0001 endotoxin units/milliliter (EU/ml).  
Endotoxin up to 5 EU/ml did not significantly increase the RAW 264.7 cells’ production of 
PGE2 in the assay (Hammer et al., 2007). 
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Figures, Legends, Formulae, Tables and References 
Table 1. Reduction in LPS-induced PGE2 and cell viability of Hp fractions and subfractions in 
RAW 264.7 mouse macrophages 
Fractionation Treatment [µg/ml] 
PGE2    
Percent of Control  
Cell Viability 
Percent of Control  
Original Ethanol Extract Extract 20 43 (28-67)* 58 ± 14* 
                     10 46 (21-98)* 97 ± 16 
Fractionation Round 1 Fraction 1A 24 25 (25-53)* 55 ± 18* 
Extract into 1A-1C  10 63 (63-100) 80 ± 17 
 Fraction 1B 22 16 (7-93)* 74 ± 13 
  10 76 (21-97) 108 ± 28 
  Fraction 1C 10 36 (23-27)* 74 ± 17 
Fractionation Round 2 Fraction 2A 40 40 (37-100) 46 ± 20* 
Fraction 1C into subfractions 2A-2D  10 59 (80-100) 96 ± 12 
 Fraction 2B 76 14 (6-29)* 46 ± 20* 
  40 42 (40-100)* 67 ± 15 
  10 100 (87-108) 113 ± 21 
 Fraction 2C 40 8 (4-18)** 40 ± 11* 
  10 44 (27-71)* 96 ± 2 
 Fraction 2D 40 17 (7-40)* 36 ± 3* 
    10 49 (20-100) 71 ± 6 
Fractionation Round 3 Fraction 3A 10 22 (10-51)** 85 ± 1 
Subfraction 2C into subfractions 3A-3F Fraction 3B 13 82 (34-100) 99 ± 3 
 Fraction 3C 5 89 (40-100) 93 ± 5 
 Fraction 3D 4 80 (33-100) 101± 5 
 Fraction 3E 4 97 (90-115) 88 ± 2 
  Fraction 3F 4 36 (24-100) 99 ± 6 
Fractionation Round 4 Fraction 4A 2 100 (74-100) 109 ± 8 
Subfraction 3A into subfractions 4A-4F Fraction 4B 4 100 (51-100) 104 ± 11 
 Fraction 4C 3 100 (64-100) 115 ± 21 
 Fraction 4D 1 100 (45-100) 93 ± 23 
 Fraction 4E 0.8 100 (50-100) 107 ± 15 
 Fraction 4F 0.7 58 (20-100) 101 ± 7 
  Fraction 4G 0.8 63 (43-100) 98 ± 5 
Mean percent of LPS-induced PGE2 level as compared to media + LPS + DMSO control (95% 
confidence intervals) and mean percent of cell viability as compared to media + DMSO control-
treated cells ± standard error of Hp fractions   n=8 for treatments.  PGE2 and cell viability data 
represents light-activated and dark treatments combined as there was no significant difference 
between the treatments.  The concentration of 10 µg/ml was chosen to compare fractions from each 
round of fractionation; fractions from rounds 3 and 4 were assayed at the highest concentration 
possible based on the amount of DMSO that can be added onto the cells.  Fractions in the culture 
 120
media without LPS did not significantly affect the concentration of PGE2 as compared to the media 
+ DMSO control. Addition of LPS to the culture media + DMSO control increased the level of 
PGE2 20-38 fold over media + DMSO control alone (0.1 ±0.05 ng/ml for media + DMSO, 2.7 ± 0.5 
ng/ml for media + DMSO + LPS).  Quercetin (10 µM) positive control significantly inhibited PGE2 
production (11(8-16) % of PGE2 control)  * p-value   0.05 as compared to control.  ** p-value   
0.001 as compared to control.   
 
Table 2.  Constituents identified and quantified (µM) in 10 µg/ml of Hp extracts, fractions and 
subfractions. 
Constituent  Extract Fraction 1C Fraction 2C Fraction 3Aa Fraction 4F 
Chlorogenic Acid 6.1 ± 0.34d 1.0 ± 0.1c  0.3 ± 0.01c 0.1 ± 0.11b 1.4 ± 0.003b 
Rutin 2.7 ± 1.7c Detected Detected - - 
Hyperoside 1.6 ± 1.5c 0.2 ± 0.002b 0.03 ± 0.01b - - 
Isoquercitrin 0.3 ± 0.1b Detected Detected - - 
Quercitrin 0.03 ± 0.01a 0.1 ± 0.01b 0.02 ± 0.04b - - 
Quercetin 0.2 ± 0.009b 0.1 ± 0.009b 0.02 ± 0.3b 0.07 ± 0.2a - 
Amentoflavone 0.2 ± 0.05b 0.09 ± 0.2ab 0.02 ± 0.4ab 0.08 ± 0.2ab - 
Pseudohypericin 0.2 ± 0.28b 0.04 ± 0.008a 0.001 ± 0.06a 0.03 ± 0.04a 0.01 ± 0.001a 
Hypericin 0.1 ± 0.03a Detected Detected Detected - 
Hyperforin 12.5 ± 0.5e 0.02 ± 0.003a Detected Detected - 
 
Constituents identified and quantified by LC-MS-UV analysis.  a Identified compounds from 
fraction 3A provided the basis for the 4 component system. Ten metabolites were quantified for the 
original extract and each of the active fractions and subfractions.  n=3 for each.  The data is 
represented as mean concentration of constituents detected in 10 µg/ml extract or fraction ± 
standard error.  This concentration was chosen to facilitate comparison of levels of constituents 
between extracts and fractions.  “Detected” indicates detection by the MS; however the amount was 
too low for quantification with standard curves generated by the UV absorption.  “-“ represents 
constituents not detected by the MS.  Mean values within each column with different superscript 
letters were significantly different a<b<c<d<e (p<0.05) and values with more than one letter were not 
significantly different than means sharing either of the letters.  Ratios of chlorogenic acid: 
quercetin: amentoflavone: pseudohypericin in the extract and fractions are: extract, 30.5:1:1:1; 
fraction 1C, 25:2.5:2.3:1; fraction 2C, 300:20:20:1, fraction 3A, 3.3:2.3:2.7:1; fraction 4F, 140:0:0:1 
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Table 3.  Reduction in PGE2 and cell viability by combinations of the putative bioactive 
constituents identified in Fraction 3A 
Treatment 
PGE2  
Percent of light-
activated control  
PGE2  
Percent of dark 
control     
Cell Viability 
Percent of  
Control      
Fraction 3A 12 (7-18)* 32 (3-48)* 85 ± 4 
Q 100 (98-100) 99 (96-105) 86 ± 16 
A 103 (96-106) 104 (99-110) 92 ± 8 
CA 115 (100-127) 122 (104-128) 103 ± 18 
PH 103 (98-109) 100 (98-114) 76 ± 11 
Q + A 90 (78-100) 92 (86-98) 116 ± 22 
CA + Q 100 (71-100) 100 (91-104) 112 ± 16 
CA + A 88 (80-99) 100 (76-108) 99 ± 7 
PH + Q 61 (39-85)* 98 (79-104)$ 87 ± 5 
PH + A 51 (16-84)* 83 (84-100)$ 96 ± 13 
PH + CA 93 (71-100) 102 (96-108) 104 ± 15 
CA + Q + A 95 (86-100) 99 (79-114) 80 ± 24 
Q + A + PH 50 (17-80)* 78 (85-99)$ 113 ± 17 
CA + Q + PH 69 (35-89)* 78 (50-98) 94 ± 13 
CA + A + PH 65 (36-96)* 74 (69-197) 101 ± 8 
CA, A, Q, PH 34 (29-36)* 78 (49-86)$ 101 ± 10 
10x CA, A, Q, PH 31 (24-35)* 68 (38-79)$ 102 ± 7 
100x CA, A, Q, PH 11 (5-17)* 53(31-59)*$ 95 ± 12 
 
Mean percent of LPS-induced PGE2 level as compared to media + LPS + DMSO control (95% 
confidence intervals) and mean percent of cell viability as compared to media + DMSO control-
treated cells ± standard error of constituents identified in fraction 3A.  n=8 for anti-inflammatory 
treatments; n=8 for cytotoxicity treatments. Q=0.07 µM quercetin, A= 0.08 µM amentoflavone, 
CA= 0.2 µM chlorogenic acid, PH= 0.03 µM pseudohypericin.  Cytotoxicity data represents light-
activated and dark treatments combined as there was no difference between light-activated versus 
dark treatments.  Constituents in the culture media without LPS did not affect the concentration of 
PGE2 as compared to the media + DMSO control. Addition of LPS to the culture media + DMSO 
control increased the level of PGE2 10-34 fold over the media + DMSO control alone (0.07 ±0.03 
ng/ml for media + DMSO, 1.6 ± 0.4 ng/ml for media + DMSO + LPS).  Quercetin (10 µM) positive 
control significantly inhibited PGE2 production (11 (8-16) % of control)  * p-value  0.05 as 
compared to control.  $ significant difference between light-activated and dark treatments. 
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Figure 1.  Representative western blots (Figure 1a) and semi-quantitative representation (Figure 1b) 
of the effect of light-activated Hp fractions (10 µg/ml) and 4 component systems on LPS-induced 
COX-1 and COX-2 protein levels in RAW 264.7 mouse macrophages.  The 4 component system is 
composed of: 0.07 µM quercetin,  0.08 µM amentoflavone, 0.2 µM chlorogenic acid, 0.03 µM 
pseudohypericin.  Data is represented as mean percent of media + DMSO + LPS control ± standard 
error.  n=4 for each.  Treatments without LPS did not significantly affect either COX-1 or COX-2 
protein as compared to media + DMSO control (average 98 ± 12% of control).  LPS increased the 
expression of COX-2 protein (29 ± 16 % of control for media + DMSO, 100 ± 17 for media + LPS 
+ DMSO) but not COX-1 protein (100 ± 15 % of control for media + DMSO).  Dark treatments did 
not significantly affect LPS-induced COX-1 or COX-2 protein levels (average 99 ±15% of control).  
Quercetin (100 µM) used as a positive control for reduction in LPS-induced COX-2 protein (27 ± 
22 % of control).  Quercetin did not affect LPS-induced COX-1 protein (103 ± 18% of control).  * 
p-value  0.05 as compared to media + LPS + DMSO control.   
 
Figure 2.  The effect of fraction 3A and 4 component system on enzyme activity of COX-1 (Figure 
2a) and COX-2 (Figure 2b) in RAW 264.7 mouse macrophages.  Q=0.07 µM quercetin, A= 0.08 
µM amentoflavone, CA= 0.2 µM chlorogenic acid, PH= 0.03 µM pseudohypericin.    Data is 
presented as mean COX-1 or COX-2 activity ± standard error (nmol/min/ml).  n=4 for each.  
Quercetin (25 µM) was used as positive control.  * p-value  0.05 as compared to media + LPS + 
DMSO control.  $ significant difference between light-activated and dark treatments. 
 
Figure 3.  Inhibition of LPS-induced cPLA2 (Figure 3a) and lipoxygenase (Figure 3b) enzyme 
activity by fraction 3A and 4 component system in RAW 264.7 mouse macrophages (mean cPLA2 
activity in µmol/min/ml ± standard error, and mean lipoxygenase activity ± standard error as 
percent of media + LPS + DMSO control).  n=4-6 for each.    Q=0.07 µM quercetin, A= 0.08 µM 
amentoflavone, CA= 0.2 µM chlorogenic acid, PH= 0.03 µM pseudohypericin.  Quercetin (25 µM) 
was used as positive control for cPLA2 and lipoxygenase. * p-value  0.05 as compared to media + 
LPS + DMSO control.  ** p-value   0.001 as compared to media + LPS + DMSO control.  $ 
significant difference between light-activated and dark treatments.   
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Figure 4.  The effect of fraction 3A and 4 component system on TNF-α production at 8 hours 
(Figure 4a) and 24 hours (Figure 4b) of treatment in RAW 264.7 mouse macrophages (mean level 
in pg/ml ± standard error).  n=3 for each.  Q=0.07 µM quercetin, A= 0.08 µM amentoflavone, CA= 
0.2 µM chlorogenic acid, PH= 0.03 µM pseudohypericin.  Quercetin (25 µM) used as positive 
control.   * p-value  0.05 as compared to media + LPS + DMSO control.   
 
Figure 5.  The effect of fraction 3A and 4 component system on IL-10 levels (mean level in pg/ml ± 
standard error) of RAW 264.7 mouse macrophages treated for 8 hours (Figure 5a) and 24 (Figure 
5b) hours.  n=3 for each.  Q=0.07 µM quercetin, A= 0.08 µM amentoflavone, CA= 0.2 µM 
chlorogenic acid, PH= 0.03 µM pseudohypericin.  Quercetin (25 µM) used as positive control.  * p-
value  0.05 as compared to media + LPS + DMSO control.  ** p-value   0.001 as compared to 
media + LPS + DMSO control.  $ significant difference between light-activated and dark 
treatments.  
     124
Figure 1.  Representative western blots (Figure 1a) and semi-quantitative representation (Figure 1b) 
of the effect of light-activated Hp fractions (10 µg/ml) and 4 component systems on LPS-induced 
COX-1 and COX-2 protein levels 
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Figure 2.  The effect of fraction 3A and 4 component system on enzyme activity of COX-1 (Figure 
2a) and COX-2 (Figure 2b). 
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Figure 3.  The effect of fraction 3A and 4 component system on LPS-induced lipoxygenase activity 
(Figure 3a) and cPLA2 activity (Figure 3b) 
3a 
 
3b 
 
 
 
     127
Figure 4.  The effect of fraction 3A and 4 component system on TNF-α production at 8 hours 
(Figure 4a) and 24 hours of treatment (Figure 4b) 
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Figure 5.  The effect of fraction 3A and 4 component system on IL-10 production at 8 (Figure 5a) 
and 24 hours (Figure 5b) 
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Abstract 
Hypericum perforatum (Hp) is commonly known for its antiviral, antidepressant, and 
cytotoxic properties, but traditionally Hp was also used to treat inflammation.  In this study, 
the anti-inflammatory activity and cytotoxicity of different Hp extractions and accessions and 
constituents present within Hp extracts were characterized.  In contrast to the antiviral 
activity of Hp, the anti-inflammatory activity observed with all Hp extracts was light-
independent.  When pure constituents were tested, the flavonoids, amentoflavone, hyperforin, 
and light-activated pseudohypericin displayed anti-inflammatory activity, albeit at 
concentrations generally higher than the amount present in the Hp extracts. Constituents that 
were present in the Hp extracts at concentrations that inhibited the production of 
prostaglandin E2 (PGE2) were pseudohypericin and hyperforin, suggesting that they are the 
primary anti-inflammatory constituents along with the flavonoids, and perhaps the 
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interactions of these constituents and other unidentified compounds are important for the 
anti-inflammatory activity of the Hp extracts. 
Introduction 
Hypericum perforatum (Hp) is an herbaceous perennial plant native to Europe and 
Asia (1).  Traditionally, Hp extracts were used both externally, for treatment of 
inflammation, wounds, and skin diseases, or internally, for treatment of anxiety, headache, 
bedwetting, neuralgia, inflammation, and mild-to-moderate depression (2).  The use of Hp 
supplements has been prevalent for many years, but increased use of these supplements and 
the identification of bioactive constituents present within Hp have intensified interest in the 
mechanisms by which Hp extracts exert specific bioactivities, such as inhibiting 
inflammation (1).   
Hp extracts possess anti-inflammatory properties in a wide variety of in vivo systems.  
The cyclooxygenase (COX) enzymes metabolize arachidonic acid to eicosanoids.  The 
products of COX-2 metabolism of arachidonic acid are the 2-series prostanoids, of which 
prostaglandin E2 (PGE2) is important in mediating pain, inflammation, and swelling (3). Raso 
et al. found that 100 mg/kg by gavage of Hp root dry powder extract twice daily significantly 
inhibited COX-2 protein levels and significantly reduced carrageenan-induced paw edema in 
mice (4).  Herold et al. reported that a hydroalcoholic Hp extract significantly inhibited 5-
lipoxygenase but did not affect COX-2 protein in cell free systems (5).    Mice fed 50-300 
mg/kg Hp extract by gavage showed a dose-related and significant inhibition of carrageenan-
induced paw edema (6).  A 50% ethanol Hp extract administered at both 100 and 200 mg/kg 
reduced inflammation and analgesia in carrageenan-induced paw edema and cotton pellet-
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induced granuloma (7), and an Hp extract suppressed inflammatory and leukocyte infiltration 
in carrageenan- and prostaglandin E1-induced Wistar rats (8).    
The minimal dose of Hp to provide a therapeutic effect is unknown; however, Hp 
treatments generally range from 500-650 mg/day and vary depending upon study design (9).  
Others report that the dosage for a fluid or powder extract would be the amount of extract 
equivalent to 0.5-3.0 mg hypericin and pseudohypericin daily (2).  Relatively few studies 
have determined the levels of many constituents present in plasma after administration of Hp 
extracts. Schulz et al. administered 612 mg of dry Hp extract to 18 healthy male volunteers as 
a single oral dose for 14 days.  The maximal plasma concentrations for hypericin, 
pseudohypericin, and quercetin were 3.14, 8.5, and 47.7 ng/mL, respectively (10). 
The bioactive constituents of Hp extracts are complex and include many different 
classes of chemicals (11).  Two of these classes of constituents are present in only select 
plant species: naphthodianthrones such as hypericin and pseudohypericin and 
phloroglucinols like hyperforin (11).  Other classes of constituents present within Hp are also 
present in many plant species; these include the flavonoids and biflavonoids, tannins, 
procyanidins, and caffeic acid derivatives, among others.  The flavonoids present in Hp are 
quercetin, the aglycone form, and its’ glycosylated derivatives, quercitrin, isoquercitrin, 
hyperoside, and rutin, while a biflavonoid present in Hp is  I3’, II8-biapigenin, also known as 
amentoflavone.   
Although individual constituents have been shown to provide bioactivity alone, the 
interaction among constituents may account for diverse bioactivities of the supplements.  
Work by Schmitt et al. supports the role of unknown compounds in the bioactivity of Hp 
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extracts in which chlorogenic acid and porphyrin, which were present in Hp extracts,  
attenuated hypericin’s light-dependent toxicity in HaCaT keratinocytes (12, 13). 
 Because comprehensive research on the anti-inflammatory constituents of Hp is 
lacking, to begin to identify the anti-inflammatory constituents we hypothesized that Hp 
extracts made using several extraction procedures and accessions would yield distinct 
chemical profiles which could be related to the anti-inflammatory activity of the Hp extracts.  
The goal of this study was to identify Hp extracts from different extraction procedures and 
Hp accessions that maximize anti-inflammatory activity in RAW 264.7 macrophage cells.  
To assess which constituents may be responsible for the anti-inflammatory activity seen in 
the extracts, constituents known to be present within Hp were also tested for anti-
inflammatory activity in the same model system. Because Hp extracts are known to possess 
cytotoxic properties, the cytotoxicity of these Hp extracts and constituents was also assessed.  
The dependence of the anti-inflammatory activity on light activation of Hp extracts, a 
treatment condition important for several Hp bioactivities, was also evaluated.  
Materials and Methods 
Plant material and extractions 
All plant material was obtained from either Frontier Natural Products Co-op (FNPC) 
(Norway, IA) or the North Central Regional Plant Introduction Station (NCRPIS) (Ames, IA) 
of the U.S. Department of Agriculture and processed as described in Schmitt et al. (12).  Six 
accessions of Hp were provided by the NCRPIS: Plant Introductions (PI) 325351 and 371528 
and the commercial varieties, Common, ‘Medizinal’ (Elixir™) (Ames 27452), ‘Helos’ 
(Ames 27453), and ‘Topas’ (Ames 27455).  Accessions PI 325351 and 371528 were 
collected in the former Soviet Union; Common was grown from seeds supplied by Johnny’s 
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Selected Seeds (Winslow, ME) and the other varieties were grown from seeds supplied by 
Richter’s Herb Specialists (Goodwood, Ontario, Canada).  ‘Topas’, bred to increase overall 
commercial production, was developed in Germany and Elixir™, bred to contain a higher 
amount of napthodianthrones, and ‘Helos’, bred for tolerance to anthracnose disease, were 
developed in Denmark (14, 15).   
Six grams of dried plant material were extracted by either Soxhlet extraction for 6 h 
or room temperature shaking for 24 h, evaporated to dryness, and dissolved in 15 mL of 
dimethyl sulfoxide (DMSO) (Sigma, St Louis, MO) as previously described (12) .  Extracts 
were stored at -30º C in the dark and used as stock solutions for treatments.  Because 
preliminary testing determined that the highest amount of DMSO that could be added onto 
the cells was 0.1% of the media and because the Hp extracts were dissolved in DMSO, each 
stock extract was added at a final DMSO concentration of 0.1% of the media that was added 
onto the RAW 264.7 cells for an initial test of anti-inflammatory activity.  Thus, the extracts 
were initially compared at different µg/ml concentrations based on adding 0.1% DMSO 
allowing comparison of the relative anti-inflammatory activity of the constituents extracted 
from 6g of dried plant material.   Hp extracts screened in this way will be referred to as 
“highest concentration tested” in this manuscript.  The stock extract was further diluted in 
DMSO to allow for comparisons of the extracts at the same (µg/mL) concentration.    
Endotoxin levels of the plant extracts were assayed using the Limulus Amebocyte 
Lysate Test (BioWhittaker, Inc.; Walkersville, MD) because the presence of high levels of 
endotoxin in the extracts would stimulate the macrophages to release inflammatory mediators 
including PGE2.   Endotoxin levels ranged from 0.001 to 0.2 endotoxin units per milliliter 
(EU/mL).  Because the extracts are further diluted in media, the range of endotoxin levels 
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present in the RAW 264.7 macrophage cell media was 0.000001-0.0002 EU/mL.  Pure 
endotoxin up to 5 EU/mL did not significantly increase the RAW 264.7 cells’ production of 
PGE2 in the assay (data not shown). 
Chemicals 
Hypericin was purchased from Molecular Probes (Eugene, OR) and pseudohypericin 
from Calbiochem-Novabiochem (La Jolla, CA).  Chlorogenic acid, quercetin, hyperoside, 
hyperforin, and rutin were purchased from Fisher Scientific (Hanover Park, IL) and 
quercitrin, isoquercitrin, and amentoflavone were purchased from ChromaDex (Santa Ana, 
CA).   
Cell culture 
RAW 264.7 macrophages were purchased from the American Type Culture 
Collection (ATCC; Manassas, VA) and cultured in high glucose Dulbecco’s Modified 
Eagle’s medium (4500 mg/L D-glucose) (Invitrogen; Carlsbad, CA) and supplemented with 
100 UI/ml penicillin/streptomycin (Invitrogen) and 10% Fetal Bovine Serum (FBS) 
(Invitrogen).  Cells were maintained in a 5% CO2 incubator with 70% humidity at  37° C 
until 70% confluent in 75 cm2 flasks.   
Cell treatments 
Cells were plated at a density of 1.0 x 105 cells/ well in 24-well cell culture plates and 
allowed to attach overnight.  Cells were incubated with or without 1 µg/mL 
lipopolysaccharide (LPS) (Escherichia coli 02B:B6) (Sigma) and solvent alone, DMSO, or 
plant extract or constituent simultaneously for 8 h.  DMSO concentration did not exceed 
0.1% of the media, an amount determined by preliminary testing.  Four controls were 
included in each treatment: media alone, media and DMSO, media and LPS, and media and 
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LPS and DMSO.  In addition, 10 µM quercetin and 6 µM baicalien were used as positive 
controls to ensure the assay was working properly. 
After initial testing of FNPC plant material in ambient light, the anti-inflammatory 
and cytotoxicity screening was always performed in both light-activated and dark conditions, 
due to the well-known light-activated properties of the naphthodianthrone compounds 
hypericin and pseudohypericin present within the Hp extracts.  Experimental conditions for 
light activation were as previously described (12).  Cell supernatants were collected on ice, 
and stored in a -70° C freezer for use in the PGE2 assay as described below.   
PGE2 assay 
The supernatant samples were assayed with a Prostaglandin E2 EIA kit (GE 
Biosciences; Piscataway, NJ) according to manufacturer’s instructions.  Supernatants were 
diluted 1:15 in water to ensure the concentration of PGE2 present within the samples were 
within the linear range of the standard curve for the assay.   
Cytotoxicity assay 
CellTiter96® Aqueous One Solution cell proliferation assay (Promega Corporation; 
Madison, WI) was used as previously described in Schmitt et al. with an 8-hour treatment 
incubation instead of 24-hour treatment incubation to parallel the anti-inflammatory studies 
(12).  Following the 8 hour incubation, treatment solutions were removed and fresh media 
and CellTiter96® dye were added for 3 hours and 15 minutes (12).  The metabolized dye 
solutions were transferred to 96-well plates for absorbance measurement at 490 nm.  The 
number of viable cells for each treatment was compared to the media + DMSO solvent 
control.  Light-activated and dark treatments of 20 µM hypericin were used as positive 
controls to ensure the assay was working properly. 
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LC-MS Analysis  
Samples in DMSO were diluted 1:2 with methanol prior to injection into an Agilent 
Technologies 100 ion trap liquid chromatography- electron spray ionization- mass 
spectrometer, with a coupled UV absorption detector (LC-MS-UV).  Standards were injected 
in triplicate for each concentration, and extracts were injected in duplicate.  A Synergi Max-
RP 150 x 4.6 mm column (Phenomenex, Torrance, CA 90501) was used for analytical 
separation.  For the mobile phase an acetonitrile/methanol (ACN/MeOH) 9:1 v/v (A) and 10 
mM ammonium acetate (B) gradient was used.  The gradient consisted of 85A/15B in 10 min 
to 80A/20B, then to 100% B in 25 minutes and held for 5 min at 40° C.  The flow rate was 
0.75 mL/min (16).  External calibration curves for standards were constructed from coupled 
UV absorption data at 254 nm. 
Concentrated stock Hp extracts were analyzed by LC-MS-UV, and calculations were 
made to estimate the concentration of constituents present in the amount of Hp extract used 
as a treatment at the highest concentration tested.  The data are presented in this way for 
comparison between the amount of constituents needed to observe an effect and amount of 
constituent that would be present in the Hp extracts when tested at the highest concentration.  
Statistical Analysis 
The anti-inflammatory data was logarithmically transformed to eliminate unequal 
variances and skewed distribution.  An F-protected two-way ANOVA was used followed by 
a Tukey-Kramer test for multiple comparisons for all PGE2 samples (17).  For the anti-
inflammatory data in tables, the data are shown as mean percent reduction in LPS-induced 
PGE2 levels ± the 95% confidence interval as compared to media + LPS + DMSO control.  
For the anti-inflammatory data presented in graphs, original PGE2 levels ± standard error are 
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shown and statistical significance was determined by an F-protected two-way ANOVA 
followed by a Tukey-Kramer test for multiple comparisons as compared to the media + LPS 
+ DMSO control.  For cytotoxicity, data were presented as mean percent reduction in cell 
viability ± standard error and the p-value was adjusted using the Dunnett-Hsu method for 
multiple comparisons against the media + DMSO control (20).  To determine light versus 
dark differences, the data was compared using the Tukey-Kramer test for multiple 
comparisons.  For LC-MS-UV detection of compounds in NCRPIS Hp extracts, data was 
presented as mean ± standard error and differences in concentrations of constituents for each 
extract was determined using a one-way ANOVA for each constituent followed by a Tukey-
Kramer test.  p values less of < 0.05 were considered to be statistically significant. 
Results  
Anti-inflammatory Activity of Extracts of FNPC Hp Plant Material Prepared by Different 
Extraction Procedures 
 To determine the relative bioactivity of material within the Hp extracts made by 
different extraction procedures, an initial screen was conducted using the FNPC Hp extracts.  
None of the extracts made from FNPC plant material significantly reduced PGE2 levels when 
added to the media without LPS (data not shown).  Soxhlet extracts generally reduced LPS-
induced PGE2 levels greater than room temperature extracts (room temperature extracts not 
shown) and all of the Soxhlet extracts significantly reduced PGE2 levels at the highest 
concentration tested (Table 1).  Although the HPLC analysis suggested that the Soxhlet and 
room temperature extracts had similar chemical profiles, the Soxhlet method extracted more 
plant material than the room temperature shaking method (12).    Only the room temperature 
70% ethanol (-chloroform) extract tested at 65 µg/mL significantly reduced LPS-induced 
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PGE2 levels by 66%.  The other room temperature extracts tested [70% ethanol, chloroform, 
hexane, and 70% ethanol (-hexane)] reduced LPS-induced PGE2 levels from 0-46% at 
concentrations ranging from 6-74 µg/mL.  Although the Soxhlet hexane extract caused the 
greatest reduction in LPS-induced PGE2 levels (81%) at the lowest concentration (17 µg/mL) 
tested in the screening among the Soxhlet FNPC extracts, Soxhlet chloroform and Soxhlet 
ethanol extracts were used for the remaining studies for two reasons.  First, ethanol extracts 
are used primarily in the supplement industry, and second, chloroform extracts do not contain 
the light-activated hypericin and pseudohypericin compounds, which allows for 
determination of the anti-inflammatory nature of other compounds in the extract under light-
activated and dark treatment conditions.  
 The cytotoxicity of the FNPC Hp extracts was reported in Schmitt et al. (12).  All of 
the ethanol and chloroform extracts and the Soxhlet hexane extract possessed significant 
cytotoxicity against NIH3T3 mouse fibroblasts, SW480 human colon cancer cells, and 
HaCaT human keratinocytes.  The concentrations of the extracts tested in Schmitt et al. (12) 
were higher than those used in the initial anti-inflammatory screen due to the greater 
sensitivity of RAW 264.7 macrophage cells to DMSO.   
Quantification of Constituents Present within NCRPIS Hp Plant Material Extracts 
 The NCRPIS Soxhlet ethanol and chloroform extracts were characterized by LC-MS-
UV for detection of constituents present within the extracts.  Chlorogenic acid was one of the 
most abundant constituents detected in the accessions (Table 2).  Higher levels of 
chlorogenic acid were observed for Soxhlet ethanol Common, ‘Helos’, and Elixir™ than PI 
325351, PI 371528, and ‘Topas’.  Rutin was the most abundant flavonoid detected in all 
accessions, whereas the levels of other flavonoids detected differed among accessions.  
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Higher levels of rutin were observed for Soxhlet ethanol Common, PI 325351, ‘Helos’ and PI 
371528, ‘Topas’ and Elixir™ than ‘Topas’ and PI 371528.  Levels of hyperforin, 
isoquercitrin, hyperoside, quercitrin, amentoflavone, hypericin, and pseudohypericin in the 
Soxhlet ethanol extracts differed among the accessions. Very few constituents were detected 
in the Soxhlet chloroform extracts, but hyperforin was the most abundant and quercitrin and 
amentoflavone were detected in selected soxhlet chloroform extracts.  Quercitrin was 
detected in the Soxhlet chloroform Common and ‘Helos’ extracts, amentoflavone was 
detected in the Soxhlet chloroform Common, ‘Helos’, and ‘Topas’ extracts, and hypericin 
was detected in the Soxhlet chloroform Elixir™ extract. 
Anti-inflammatory Activity and Cytotoxicity of NCRPIS Hp Accession Extracts 
 An initial screen was conducted using the NCRPIS Soxhlet ethanol and chloroform 
Hp accession extracts at the concentration extracted from 6 g of dried plant material.    None 
of the extracts significantly reduced the level of PGE2 produced without LPS (data not 
shown).  No differences between light-activated and dark treatments were observed, and data 
were pooled across this variable for presentation.  The accession Elixir™ (8 µg/mL) Soxhlet 
chloroform extract reduced LPS-induced PGE2 levels (43% reduction) at the lowest 
concentration observed in this screening (Table 3).  All Soxhlet ethanol extracts of Hp 
accessions were able to significantly reduce LPS-induced PGE2 levels, albeit at higher 
concentrations than in the Soxhlet chloroform extracts.  Next, we tested both the Soxhlet 
chloroform and Soxhlet ethanol extracts of four Hp accessions at 8 µg/mL (Figure 1). 
Accession Elixir™ reduced LPS-induced PGE2 levels in both the Soxhlet chloroform and 
Soxhlet ethanol extracts.  The other accessions exhibited little anti-inflammatory activity at 
this dose.   
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 The cytotoxicity of the NCRPIS Hp extracts was also assessed.  There was no 
significant difference between light-activated and dark treatments for any of the Hp extracts 
and data were pooled across this variable.  All Hp extracts tested at their highest 
concentration produced significant cytotoxicity as compared to the solvent control except for 
the Soxhlet chloroform Elixir™ extract at 8 µg/mL (Table 3).  Reductions in PGE2 levels 
ranged from 89-93% and 43- 85% for Soxhlet ethanol and chloroform extracts, respectively, 
whereas the percent reductions in cell viability were 35-41% and 23-49%, respectively.  
Therefore, some of the reduction in PGE2 may have been due to cytotoxicity in the RAW 
264.7 macrophage cells.   However, none of the Hp extracts assayed at 8 µg/mL produced 
statistically significant cytotoxicity (4-23% reductions in cell viability in chloroform extracts, 
23-28% reductions in cell viability in ethanol extracts) suggesting that the anti-inflammatory 
activity of accession Elixir™ at 8 µg/mL (43 and 47% reductions for chloroform and ethanol, 
respectively) was not simply due to cytotoxicity of the cells (Table 4).  To further support 
this, no reductions in LPS-induced PGE2 levels were observed with ‘Helos’, PI 371528, and 
‘Topas’ at 8 µg/mL, despite 17-22% reductions in cell viability, suggesting that this range of 
cytotoxicity was not directly reflected in PGE2 levels in this assay (Table 4).     
To further evaluate the activities of these Hp extracts, dose-response studies were 
conducted for Soxhlet ethanol extracts of accessions Common, PI 371528, and Elixir™.  
Soxhlet ethanol extracts of accessions PI 371528 and Elixir™ showed a dose-dependent 
inhibition of PGE2 at higher concentrations (Figure 2).  At lower concentrations, only 
accession Elixir™ was able to significantly reduce PGE2.  Significant cytotoxicity was 
observed for PI 371528 at 11.5, 15, and 30 µg/mL and for Elixir™ at 30 µg/mL (Table 4).  
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Thus, some of the reductions in PGE2 levels in these Soxhlet ethanol Hp accession extracts 
could be due to cytotoxicity.  
Anti-inflammatory Activity and Cytotoxicity of Constituents Identified within Hp Extracts 
The anti-inflammatory activity of constituents identified within Hp extracts 
(hyperforin, quercetin, quercitrin, isoquercitrin, rutin, hyperoside, amentoflavone, 
chlorogenic acid, pseudohypericin, and hypericin) was studied.  Because there was no 
significant difference between dark and light-activated treatments for most constituents, data 
were pooled across this variable in Table 5.  Pseudohypericin and hypericin were the only 
constituents that displayed differences between dark and light-activated treatments and are 
displayed in Figure 3.  Hyperforin significantly decreased PGE2 levels at 40 and 80 µM. 
Quercetin significantly reduced PGE2 at 5-40 µM (Table 5).  Quercitrin and isoquercitrin 
reduced PGE2 levels at 5-20 µM.  Rutin was the only flavonoid that did not significantly 
reduce LPS-induced PGE2 levels at the doses tested.  Amentoflavone significantly reduced 
PGE2 levels at 10 µM.   Chlorogenic acid did not reduce PGE2 levels at concentrations up to 
40 µM.  The range of concentrations of the individual constituents tested for bioactivity 
spanned the amounts detected in the extracts as tested at the highest concentration for each 
extract (Table 2).   Constituents that were not detected within the extracts or detected at 
levels too low to quantify were not included in this concentration range.  Although 
amentoflavone concentrations in the Hp extracts at their highest concentration ranged from 
0.2 to 2 µM, since 10 µM amentoflavone was needed to significantly reduce PGE2 levels, 
amentoflavone was not tested at concentrations below 1 µM. 
The cytotoxicity of the constituents identified within Hp extracts was also assessed. 
No significant differences between light-activated and dark treatments were observed for 
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constituents except for pseudohypericin and hypericin (Table 6 and Figure 3A).  Significant 
cytotoxicity was observed with 20 µM isoquercitrin and hyperoside (40% and 35% 
reductions in cell viability, respectively) (Table 5).  However, 20 µM isoquercitrin and 
hyperoside also significantly reduced PGE2 levels to a greater extent (66% and 56% 
reductions, respectively) (Table 6), suggesting that although there was cytotoxicity present at 
this dose, it probably did not account for all the reduction in PGE2. 
Hypericin at 2 µM produced significantly greater cytotoxicity in light-activated 
treatments than in the dark, with no reductions in PGE2 (Table 6).  Hypericin at 20 µM 
increased PGE2 levels both with and without LPS in the light-activated condition (Figure 
3A).  Hypericin at 20 µM produced significant cytotoxicity in light-activated conditions but 
not in the dark, and a significant difference between light-activated and dark treatments was 
observed (Table 6).  Hypericin at 20 µM exhibited 86% reduction in cell viability while 
significantly increasing PGE2 levels, thus, the increase in PGE2 by 20 µM hypericin may 
have been attenuated by this cytotoxicity. 
Pseudohypericin exhibited light-activated effects on both PGE2 levels and 
cytotoxicity.  When light-activated at 2 µM, pseudohypericin slightly but significantly 
increased PGE2 levels as compared to control when LPS was not added (Figure 3B).  
Pseudohypericin at 1 and 2 µM significantly reduced LPS-induced PGE2 levels in light-
activated but not dark treatments (Figure 3B).  Pseudohypericin at 0.02, 0.2, and 0.5 µM did 
not alter PGE2 production without or with LPS. Pseudohypericin at 1 and 2 µM produced 
significant cytotoxicity in light-activated conditions and there were significant differences 
between light-activated and dark treatments for 1 and 2 µM pseudohypericin (Table 6).   The 
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cytotoxicity of light-activated pseudohypericin may have contributed to the reduction in 
PGE2 production in the light. 
Discussion 
Many studies have assessed the anti-inflammatory activity of Hp extracts both in cell 
culture and in vivo (4-8).  These previous studies usually examined one Hp extract made 
from one extraction procedure and from a single accession of Hp.  The present paper expands 
upon the earlier studies; however, since our work involved assessing anti-inflammatory 
activity by only one assay, LPS-induced PGE2 production, other anti-inflammatory endpoints 
must be studied to further extend these observations.  The identification of accessions and 
extraction procedures that exhibit greater anti-inflammatory activity with less cytotoxicity 
may lead to improved Hp botanical supplements. Furthermore, although cytotoxicity and 
anti-viral studies are often performed in light-activated and dark treatment conditions, the 
light-dependence of the anti-inflammatory activity of Hp extracts had not been studied. To 
our knowledge, this is the first report demonstrating that the anti-inflammatory activity of Hp 
extracts is light-independent. The Hp accessions tested displayed different anti-inflammatory 
activities at the highest concentrations tested with the greatest inhibition of PGE2 production 
(93% reduction) with Soxhlet ethanol accessions of PI 325351, PI 371528, and ‘Helos’, 
which may reflect the genetic background or developmental differences among accessions.   
Accession Elixir™ clearly exhibited the greatest anti-inflammatory activity at lower 
concentrations in both Soxhlet chloroform and Soxhlet ethanol extractions. It is interesting 
that no differences were observed between light-activated and dark treatments for anti-
inflammatory activity contrary to previously reported results for anti-viral and other 
bioactivities (1, 12, 13, 19), suggesting that the constituents present within Hp extracts that 
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exerted anti-inflammatory activity were not dependent on light-activation. Furthermore, both 
Soxhlet ethanol and Soxhlet chloroform Elixir™ extracts exhibited similar anti-inflammatory 
activity at 8 µg/mL suggesting that the compounds responsible for anti-inflammatory activity 
may be extracted in both ethanol and chloroform.    However, the only common constituent 
that was detected by LC-MS-UV analysis in both of the Elixir™ extracts was hypericin.  
Hypericin tested as a pure constituent did not reduce PGE2 levels, suggesting that unknown 
compounds within these two extracts may explain the greater anti-inflammatory activity of 
Elixir™.    
Because hypericin has been shown to inhibit 12-lipoxygenase (20) and inhibit the 
release of arachidonic acid in human granulocytes (21), treatments with hypericin were 
performed to determine the effect of light-activation on anti-inflammatory activity.  
Hypericin showed no reduction in LPS-induced PGE2 levels as compared to controls in light-
activated or dark treatments up to concentrations of 20 μM.  Because hypericin 
concentrations between 0.05 and 0.2 µM would be present in the highest concentration of 
extract tested, it is unlikely that hypericin present within the Hp extract was reducing PGE2 
levels.  The concentration of pure hypericin needed to observe an effect was 20 µM both with 
and without LPS, but this was a pro-inflammatory effect.  Furthermore, 20 µM hypericin was 
significantly cytotoxic to the RAW 264.7 macrophage cells.  This is the first report of 
hypericin’s effect on PGE2 levels in LPS-induced RAW 264.7 macrophages.   
Pseudohypericin displayed light-activated properties.  Pseudohypericin reduced PGE2 
with LPS and increased PGE2 without LPS.    In a lipoxygenase activity assay, 
pseudohypericin inhibited 12-lipoxygenase, although light conditions were not described 
(20).  These results support the role of pseudohypericin as an anti-inflammatory compound in 
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stimulated cells, although data from Hp extracts presented here suggest that compounds 
responsible for the anti-inflammatory activity of extracts were not light-activated. The 
concentration of pseudohypericin needed to observe an anti-inflammatory effect was 1 µM, 
while the concentration of pseudohypericin present in the highest concentration of extract 
tested was 0.3-1 µM; thus, it is possible that pseudohypericin contributed at least to some 
extent to the anti-inflammatory activity of Hp extracts.  
Hyperforin inhibited LPS-induced PGE2 levels at 40 and 80 μM.  The hyperforin 
concentration in Hp extracts at the highest concentration tested was 1-70 μM.  Therefore, 
higher concentrations of hyperforin may be contributing to the anti-inflammatory activity of 
Hp extracts. Albert et al. showed that hyperforin suppressed COX-1 product formation with 
an IC50 of 0.3 μM for thrombin-stimulated or 3 μM for ionophore-stimulated human 
monocytic MM6 (Mono Mac 6) cells, but hyperforin had no effect on COX-2 protein levels 
in LPS-stimulated MM6 cells (22).  This is the first report of hyperforin’s effects in RAW 
264.7 macrophage cells. 
Similar to our results with flavonoids, 40 and 80 μM quercetin significantly decreased 
LPS-induced PGE2 levels in RAW 264.7 macrophage cells at 40 and 80 μM while decreasing 
COX-2 protein at 80 μM (23).  Furthermore, rutin had no effect on LPS-induced PGE2 levels 
or COX-2 protein levels in RAW 264.7 macrophages at 40 and 80 µM (23).  Chlorogenic 
acid at 1-40 µM had no significant effect on LPS-induced PGE2 levels in RAW 264.7 
macrophages and 10 µM chlorogenic acid would be present in the Hp extracts at the highest 
concentration tested. Chlorogenic acid had no effect on LPS-induced PGE2 levels in J774 
macrophages up to 100 µM (24).   
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Although cytotoxicity was observed at the highest concentration tested for all the Hp 
extracts except for the Soxhlet chloroform Elixir™, no significant cytotoxicity was observed 
at 8 µg/mL for the Hp accession extracts. However, the extracts did possess some moderate 
cytotoxicity that was not statistically significant.  The reduction in PGE2 for both the Hp 
extracts and constituents cannot be explained by cytotoxicity alone as evidenced by the Hp 
extracts at lower doses and the constituents and in agreement with Schmitt et al. the Hp 
extracts exhibited light-independent cytotoxicity while the naphthodianthrones had light-
dependent cytotoxicity (12).   
In conclusion, Hp extracts possessed anti-inflammatory activity that varied with 
extraction solvent and accession. The profiles of known chemical constituents, flavonoids, 
biflavonoids, phloroglucinols and naphthodianthrones, varied among the different accessions 
tested.  Accession Elixir™ displayed the most anti-inflammatory activity at lower 
concentrations; both Soxhlet ethanol and Soxhlet chloroform extracts were active at a 
concentration of 8 µg/mL.  The cytotoxicity of Elixir™ at 8 µg/ml was not statistically 
significant and cannot solely account for the reductions in PGE2.    Finally, flavonoids, 
biflavonoids, phloroglucinols, and pseudohypericin were present within the extracts and 
possessed significant anti-inflammatory activity; however, the concentrations of these 
constituents in the Hp extracts at the highest concentration tested was far less than the 
concentration of pure constituent needed to observe a significant anti-inflammatory effect, 
with the exception of light-activated pseudohypericin at 1 µM in two of the Hp extracts and 
hyperforin at 70 μM in one of the Hp extracts.  Thus, the anti-inflammatory activity of Hp 
extracts cannot be explained by the presence of these constituents alone. Because Hp extracts 
showed light-independent anti-inflammatory activity, it is likely that interactions among 
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identified and unidentified compounds account for the diverse activities seen in different 
accessions of Hp.   
Abbreviations Used 
Hp, Hypericum perforatum; PI, Plant Introduction; FNPC, Frontier Natural Products Co-op; 
NCRPIS, North Central Regional Plant Introduction Station; PGE2, Prostaglandin E2; LPS, 
Lipopolysaccharide. 
Safety 
Organic solvents, such as hexane and chloroform, are toxic chemicals and should be properly 
handled in a fume hood. 
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Table 1.  Anti-inflammatory activity of extracts of FNPC Hp plant material prepared by 
different Soxhlet extraction procedures of dried Hp and tested at concentrations that represent 
the relative amount extracted from 6 g of plant material 
 
 
Soxhlet extraction 
[µg/mL] 
testeda 
% reduction in 
LPS-induced PGE2 b 
(95% CI) 
70% ethanol 116 78 (64-87)** 
chloroform 43 79 (64-87)** 
hexane 17 81 (61-91)** 
70% ethanol (-hexane) 65 73 (55-84)** 
70% ethanol(-chloroform) 69 82 (62-91)** 
 
a Concentration tested in µg/mL represents the final concentration of the extract in the media. 
Anti-inflammatory activity [b mean percent reduction in LPS-induced PGE2 levels as 
compared to media + LPS + DMSO control (95% confidence intervals)] was screened using 
the PGE2 assay (n=4 for each) in ambient light.  Addition of LPS to the culture media + 
DMSO control increased the level of PGE2 24-fold over media + DMSO control alone (0.08 
± 0.03 ng/mL for media + DMSO, 1.9 ± 0.3 ng/mL for media + DMSO + LPS).  Extracts in 
the culture media without LPS did not affect the concentration of PGE2 as compared to the 
media + DMSO control. **, p value < 0.0001 as compared to control. 
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Table 2.  Constituents identified and quantified within NCRPIS Hp extractsa 
1         
± 0.04 a---------
chlorofo
rm
8         
± 0.02
b, c
0.04                
±
0.005 a
0.2                  
±
0.05 a
detected
0.2                
± 0.02
a
0.1            
± 0.02
a, b
0.4                 
±0.02 a
3                
± 0.06 a
9                
±
0.02 a
10                     
± 0.1 aethanol'Topas'
-detected--------
chlorofo
rm
11        
± 0.05 c
0.6              
±
0.0004
c
0.7                 
±
0.04 b, 
c
0.7                       
± 0.06 a
0.5                
±
0.02 b
0.2             
± 0.02 b
0.8                
± 0.01 b
7                
± 0.05 c
11              
±
0.03 b
25                     
± 0.2 bethanol
Elixir
™
6         
± 0.04 b--detected-
0.07                
± 0.02 a----
chlorofo
rm
70        
± 0.02 e
0.4               
±
0.0005
b
1                        
±
0.01 c
2                         
± 0.06 b
0.8              
±
0.02 c
0.3              
± 0.02 c
2                   
± 0.0006
c
7                 
± 0.03 c
13               
± 0.5 b
28                  
± 0.2 bethanol'Helos'
7         
± 0.01
b, c
---------chloroform
17        
± 0.03 d
0.06                
± 3.9 a
0.3                     
±
0.006
a
0.2                      
± 0.06 a
0.2               
±0.02
a
0.1             
± 0.02
a, b
0.9                
± 0.01 b
4                
± 0.02
a, b
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±
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PI 
371528
5         
± 0.04 b
---------chloroform
11        
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0.1             
± 2.5 a
0.5                     
±
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b
0.2                     
± 0.06 a
0.5              
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b
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0.5
± 0.006 a
3                 
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13          
± 0.1 b
13                  
± 0.5 a
ethanolPI 325351
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± 0.05 c--detected-
0.08                
± 0.02 a----
chlorofo
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22        
± 0.05
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± 0.05 a
1                        
± 0.05
c
0.5                      
± 0.006 a
1                 
± 0.02
c
0.2             
± 0.02 b
1                    
± 0.01 b
5                 
± 0.02 b
15               
± 0.02
b
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± 0.1 bethanol
Comm
on
hyperfo
rin
hyperic
in
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o
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cin
amentoflavo
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querce
tin
quercitr
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chloroge
nic acidextract
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compound concn ( µM )
 
aCompounds identified and quantified by LC-MS-UV analysis.  Hp extracts were analyzed in 
the concentrated stock extract, and calculations were made to estimate the concentration of 
constituents present in the amount of Hp extract used for treatment denoted as highest 
concentration tested in this paper.  Ten metabolites from 12 Soxhlet Hp extracts were 
 
   
 
156
quantified.  The data are represented as mean concentration ± standard error.  “Detected” 
indicates detection by the MS; however, the amount was too low for quantification with the 
UV absorption data. “–” represents compounds not detected by the MS.  Mean values within 
each column with different letters were significantly different ( a<b<c<d<e ) (p<0.05), and 
values with more than one letter were not significantly different from means sharing either of 
the letters.  
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Table 3.  Anti-inflammatory activity and cytotoxicity of NCRPIS accessions of dried Hp 
plant material tested to represent the relative amount extracted from 6 g of plant material 
 chloroform ethanol 
Accession 
[µg/mL] 
testeda 
% reduction in 
LPS-induced 
PGE2 b  
(95% CI) 
% reduction 
in cell 
viabilityc 
(±SE) 
[µg/mL] 
Testeda 
% reduction in 
LPS-induced 
PGE2 b  
(95% CI) 
% 
reduction 
in cell 
viabilityc 
(±SE) 
Common 14 50 (7-74)* 35 ± 4* 73 91 (87-94)** 38± 5*  
PI 325351 15 66 (36-82)* 41 ± 7** 147 93 (83-93)**  40 ± 6* 
PI 371528 12 80 (62-89)** 49 ± 3** 65 93 (84-93)** 41 ± 7** 
‘Helos’ 16 73 (49-85)* 49 ± 3 ** 181 93 (85-93)** 35 ± 2* 
Elixir™ 8 43 (35-51)* 23 ± 11  122 89 (75-89)** 36 ± 4*  
‘Topas’ 29 85 (73-92)** 32 ± 3* 110 92 (83-93)** 41 ± 4*  
 
a The concentration tested in µg/mL represents the final concentration of the extract in the 
media. Anti-inflammatory activity [b mean % reduction in LPS-induced PGE2 levels as 
compared to media + LPS + DMSO control (95% confidence intervals)] and cytotoxicity (c 
mean % reduction in cell viability as compared to media + DMSO control-treated cells ± 
standard error) of Hp extracts (n=8 for each).  Data represent light-activated and dark 
treatments combined as there were no significant differences between the light-activated and 
dark treatments for any of the extracts.  Addition of LPS to the culture media + DMSO 
control increased the level of PGE2 36-fold over media + DMSO control alone (0.16 ± 0.03 
ng/mL for media + DMSO, 2.9 ± 0.22 ng/mL for media + DMSO + LPS).  Extracts in the 
culture media without LPS did not affect the concentration of PGE2 as compared to the 
media + DMSO control. *, p value less than 0.05 as compared to control.  **, p value less 
than 0.0001 as compared to control.
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Table 4. Cytotoxicitya of NCRPIS Soxhlet ethanol extracts of Accessions Common, PI 
371528, Elixir™, ‘Helos’ and ‘Topas’. 
accession extraction 
[ 
µg/mL] 
testedc 
% reduction 
in cell 
viability  
(±SE)  
Common ethanol 30 30 ± 6 
  15 20 ± 9 
  11.5 16 ± 13 
  8 17 ± 10 
PI 371528 ethanol 30 44 ± 8* 
  15 42 ± 6* 
  11.5 34 ± 13* 
  8 22 ± 3 
PI 371528 chloroform 8 22 ± 10 
Elixir™ ethanol 30 37 ± 3* 
  15 24 ± 8 
  11.5 25 ± 9 
  8 23 ± 10 
  5 18 ± 6 
  1 15 ± 11 
Elixir™ chloroform 8 23 ± 11 
‘Helos’ ethanol 8 23 ±10 
‘Helos’ chloroform 8 4 ± 8 
‘Topas’ ethanol 8 27 ± 11 
 ‘Topas’  chloroform 8 22 ± 10 
 
aCytotoxicity (b mean percent reduction in cell viability as compared to media + DMSO 
control-treated cells ± standard error) of Hp extracts (n=8 for each). c The concentration 
tested in µg/mL represents the final concentration of the extract in the media. Data represents 
light-activated and dark treatments combined as there were no significant differences 
between the light-activated and dark treatments for any of the extracts.  *, p value <0.05 as 
compared to control.
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Table 5.  Anti-inflammatory activitya and cytotoxicity of constituents identified within Hp 
extracts. 
class constituent concn (µM) 
% reduction in 
LPS-induced 
PGE2 b           
(95% CI) 
% reduction 
in cell 
viabilityc 
(±SE) 
phloroglucinol hyperforin 0.02, 2, 5, 10 0 (0-36) 3 ± 8 
   20 14 (0-43) 22 ± 6 
   40 48 (22-66)* 28 ± 4 
   80 62 (43-75)* 34 ± 11 
flavonoid quercetin 0.2, 2 0 (0-52) 0 ± 4 
   5 66 (21-85)* 1 ± 13 
   10 87 (78-92)** 14 ± 15 
   20 93 (84-97)** 29 ± 12 
   40 96 (90-98)** 33 ± 11 
  quercitrin 0.02, 0.2 0 (0-60) 0 ± 4 
   2 36 (0-72) 3 ± 8 
   5 54 (11-77)* 9 ± 9 
   10 67 (35-83)* 18 ± 20 
   20 71 (22-87)* 33 ± 15 
  isoquercitrin 0.02 0 (0-47) 0 ± 5 
   0.2 9 (0-53) 0 ± 12 
   2 31 (0-64) 13 ± 7 
   5 60 (8-83)* 22 ± 12 
   10 62 (23-85)* 23 ± 13 
   20 66 (43-94)* 40 ± 8* 
  rutin 0.2, 2, 5 0 (0-41) 0 ± 12 
   10 7 (0-57) 17 ± 8 
   20 17 (0-59) 18 ± 7 
   40 24 (10-60) 19 ± 16 
  hyperoside 0.2 8 (0-33) 22 ± 20 
   2 27 (0-63) 29 ± 10 
   5 42 (0-70) 33 ± 17 
   10 51 (5-75)* 37 ± 13 
   20 56 (15-78)* 35 ± 6* 
biflavonoid amentoflavone 1 38 (0-73) 8 ± 4 
   5 53 (0-79) 13 ± 5 
   10 77 (46-90)* 15 ± 14 
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other chlorogenic Acid 1, 5, 10, 20, 40 0 (0-54) 0 ± 6 
 
 
aAnti-inflammatory activity [b mean percent reduction in LPS-induced PGE2 level as 
compared to media + LPS + DMSO control (95% confidence intervals)] and cytotoxicity 
(cmean percent reduction in cell viability as compared to media + DMSO control-treated cells 
± standard error) (n=8 for anti-inflammatory treatments; n=8 for cytotoxicity treatments) of 
pure compounds identified within Hp extracts on RAW 264.7 macrophage cells.  Data 
represents light-activated and dark treatments combined as there was no difference between 
light versus dark treatments.  Pure compounds in the culture media without LPS did not 
affect the concentration of PGE2 as compared to the media + DMSO control. Addition of 
LPS to the culture media + DMSO control increased the level of PGE2 15 to 35-fold over 
media + DMSO control alone.  *, p value less than 0.05 as compared to control.  **, p value 
less than 0.0001 as compared to control.
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Table 6.  Cytotoxicitya of hypericin and pseudohypericin. 
  
% reduction in cell viabilityb (±SE)  
treatment concn (µM) 
dark 
(± SE) 
light-activated 
(± SE) 
light v. dark 
statistical 
significance 
hypericin 0.02 0 ± 6 4 ± 8 - 
  0.5 0 ± 12 8 ± 3 - 
  2 8 ± 13 15 ± 4 # 
  20 23 ± 5 86 ± 3** ## 
pseudohypericin 0.02 0 ± 13 7 ± 9 - 
  0.2 10 ± 8 12 ± 8 - 
  0.5 22 ± 4 17 ± 11 - 
  1 20 ± 5 30  ± 4* # 
  2 26 ± 10 43  ± 7* # 
aThe cytotoxicity (bmean percent reduction in cell viability as compared to media + DMSO 
control-treated cells ± standard error) of pseudohypericin and hypericin was tested in RAW 
264.7 macrophage cells in both light-activated and dark treatments (n=4 for each).  *,  p 
value < 0.05 as compared to control.  **,  p value  < 0.0001 as compared to control. #, p 
value < 0.05 when light and dark treatments were compared.  ##,  p value < 0.0001 when 
light and dark treatments were compared. 
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Figure legends 
Figure 1. 
Anti-inflammatory activity was screened using the PGE2 assay (n=8 for each).  Data are 
presented as mean LPS-induced PGE2 level ± standard error.  Data represents light-activated 
and dark treatments combined as there were no significant differences between light-
activated and dark treatments for each extract.  Addition of LPS to the culture media + 
DMSO control increased the level of PGE2 20 fold over media + DMSO control alone (0.1± 
0.05 ng/mL for media + DMSO, 2.4 ± 0.3 ng/mL for media + LPS + DMSO).  Extracts in the 
culture media without LPS did not affect the concentration of PGE2 as compared to the 
media + DMSO control.  *,  p value <0.05 as compared to media + DMSO control.   
 
Figure 2. 
Anti-inflammatory activity was screened using the PGE2 assay (n=8 for each).  Data 
presented as mean LPS-induced PGE2 level ± standard error.  Controls were the same for 
each accession tested and are represented as a single bar.  Elixir™ at 5 and 1 µg/mL did not 
significantly reduce PGE2 levels as compared to control with values of 1.7 ± 0.3 and 2.1 ± 
0.5, respectively (data not shown).  Data represents light-activated and dark treatments 
combined as there were no significant differences between light-activated and dark 
treatments for each extract.  Addition of LPS to the culture media + DMSO control increased 
the level of PGE2 13 fold over media + DMSO control alone (0.1± 0.02 ng/mL for media + 
DMSO, 1.7 ± 0.2 ng/mL for media + LPS + DMSO).  Extracts in the culture media without 
LPS did not affect the concentration of PGE2 as compared to the media + DMSO control.    
*,  p value <0.05 as compared to media + DMSO control.   
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Figure 3. 
Anti-inflammatory activity (mean PGE2 level ± standard error) of hypericin and 
pseudohypericin was screened using the PGE2 assay (n=4). Addition of LPS to the culture 
media + DMSO control increased the level of PGE2 12-fold over media + DMSO control 
alone (0.18± 0.09 ng/mL for media + DMSO, 2.1 ± 0.3 ng/mL for media + LPS + DMSO) 
for pseudohypericin and 18 fold (0.17 ± 0.02 ng/mL for media + DMSO, 3.0 ± 0.6 ng/mL for 
media + DMSO + LPS) for hypericin.  *,  p value <0.05 as compared to media + DMSO or 
media + LPS + DMSO control.  #,  p value <.05 for significant difference between light-
activated and dark treatments for corresponding dose.   
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Figure 1.  Anti-inflammatory activity of accessions of Soxhlet ethanol and chloroform 
NCRPIS Hp extracts at 8 µg/mL.   
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Figure 2.  Anti-inflammatory dose-response of Soxhlet ethanol extracts of accessions 
Common, PI 371528, and Elixir™.  
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Figure 3.  Anti-inflammatory activity of hypericin (A) and pseudohypericin (B) 
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